| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cytoskeletal protein binding | KIF13B DLG5 CENPF SYNE1 SPTA1 SPTBN2 ARFGEF1 GBP2 TUBGCP4 CEP350 TTBK2 DST SYNE2 PLEC DMD USH2A UTRN FKBP4 UNC13A | 6.27e-06 | 1099 | 108 | 19 | GO:0008092 |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 1.18e-04 | 18 | 108 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | ferric-chelate reductase (NADPH) activity | 2.87e-04 | 5 | 108 | 2 | GO:0052851 | |
| GeneOntologyMolecularFunction | ferric-chelate reductase activity | 2.87e-04 | 5 | 108 | 2 | GO:0000293 | |
| GeneOntologyMolecularFunction | cupric reductase (NADH) activity | 2.87e-04 | 5 | 108 | 2 | GO:0008823 | |
| GeneOntologyMolecularFunction | cytoskeleton-nuclear membrane anchor activity | 2.87e-04 | 5 | 108 | 2 | GO:0140444 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 4.57e-04 | 28 | 108 | 3 | GO:0051959 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 5.64e-04 | 70 | 108 | 4 | GO:0003777 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on metal ions, NAD or NADP as acceptor | 5.98e-04 | 7 | 108 | 2 | GO:0016723 | |
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | 7.06e-04 | 130 | 108 | 5 | GO:0005200 | |
| GeneOntologyMolecularFunction | DNA topoisomerase activity | 7.94e-04 | 8 | 108 | 2 | GO:0003916 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 1.05e-03 | 37 | 108 | 3 | GO:0045505 | |
| GeneOntologyMolecularFunction | actin binding | 1.17e-03 | 479 | 108 | 9 | GO:0003779 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | 1.52e-03 | 599 | 108 | 10 | GO:0050839 | |
| GeneOntologyMolecularFunction | dystroglycan binding | 1.85e-03 | 12 | 108 | 2 | GO:0002162 | |
| GeneOntologyMolecularFunction | FK506 binding | 1.85e-03 | 12 | 108 | 2 | GO:0005528 | |
| GeneOntologyMolecularFunction | vinculin binding | 2.17e-03 | 13 | 108 | 2 | GO:0017166 | |
| GeneOntologyBiologicalProcess | centrosome localization | 3.41e-05 | 35 | 109 | 4 | GO:0051642 | |
| GeneOntologyBiologicalProcess | chromosome segregation | CENPF SYCP3 SYCE3 TUBGCP4 SMC2 CENPH ASPM SMARCC1 TOP1 TOP2A CDC23 | 3.58e-05 | 465 | 109 | 11 | GO:0007059 |
| GeneOntologyBiologicalProcess | microtubule organizing center localization | 3.82e-05 | 36 | 109 | 4 | GO:0061842 | |
| GeneOntologyBiologicalProcess | microtubule-based process | KIF13B SPEM3 DNAH10 DYNC2H1 TUBGCP4 KIAA0753 DNAH1 CEP350 TTBK2 SLC9C1 DST CENPH SYNE2 VPS13A ASPM FKBP4 PCNT | 3.90e-05 | 1058 | 109 | 17 | GO:0007017 |
| GeneOntologyBiologicalProcess | organelle assembly | RPGRIP1 CENPF DYNC2H1 SYNE1 SPTBN2 RNF213 TUBGCP4 KIAA0753 DNAH1 CEP350 TTBK2 CENPH SYNE2 ASPM UBXN2A PLEC PCNT | 9.59e-05 | 1138 | 109 | 17 | GO:0070925 |
| GeneOntologyBiologicalProcess | chromosome separation | 1.04e-04 | 88 | 109 | 5 | GO:0051304 | |
| GeneOntologyBiologicalProcess | copper ion transport | 1.53e-04 | 20 | 109 | 3 | GO:0006825 | |
| GeneOntologyBiologicalProcess | female meiosis chromosome separation | 1.65e-04 | 4 | 109 | 2 | GO:0051309 | |
| GeneOntologyBiologicalProcess | kinetochore organization | 1.78e-04 | 21 | 109 | 3 | GO:0051383 | |
| GeneOntologyCellularComponent | extrinsic component of postsynaptic endosome membrane | 2.64e-05 | 2 | 108 | 2 | GO:0098999 | |
| GeneOntologyCellularComponent | cilium | RPGRIP1 CFAP95 DLG5 DNAH10 CENPF DYNC2H1 DNAH1 USP26 TTBK2 SLC9C1 KCNU1 VPS13A FLCN USH2A PCNT | 5.85e-05 | 898 | 108 | 15 | GO:0005929 |
| GeneOntologyCellularComponent | extrinsic component of endosome membrane | 1.58e-04 | 4 | 108 | 2 | GO:0031313 | |
| GeneOntologyCellularComponent | filopodium membrane | 1.67e-04 | 21 | 108 | 3 | GO:0031527 | |
| GeneOntologyCellularComponent | microtubule organizing center | DLG5 FAM184A CENPF TUBGCP4 CCDC141 KIAA0753 CEP350 TTBK2 ITSN2 ASPM FLCN USH2A TOP2A PCNT | 2.73e-04 | 919 | 108 | 14 | GO:0005815 |
| GeneOntologyCellularComponent | microtubule | KIF13B CFAP95 DNAH10 DYNC2H1 TUBGCP4 DNAH1 DST ASPM FKBP4 PCNT | 4.42e-04 | 533 | 108 | 10 | GO:0005874 |
| GeneOntologyCellularComponent | motile cilium | 5.15e-04 | 355 | 108 | 8 | GO:0031514 | |
| GeneOntologyCellularComponent | cytoplasmic region | 5.65e-04 | 360 | 108 | 8 | GO:0099568 | |
| GeneOntologyCellularComponent | organelle outer membrane | 6.19e-04 | 279 | 108 | 7 | GO:0031968 | |
| GeneOntologyCellularComponent | outer membrane | 6.46e-04 | 281 | 108 | 7 | GO:0019867 | |
| GeneOntologyCellularComponent | axoneme | 7.26e-04 | 207 | 108 | 6 | GO:0005930 | |
| GeneOntologyCellularComponent | ciliary plasm | 7.44e-04 | 208 | 108 | 6 | GO:0097014 | |
| GeneOntologyCellularComponent | spectrin-associated cytoskeleton | 9.30e-04 | 9 | 108 | 2 | GO:0014731 | |
| GeneOntologyCellularComponent | spectrin | 9.30e-04 | 9 | 108 | 2 | GO:0008091 | |
| GeneOntologyCellularComponent | male germ cell nucleus | 1.03e-03 | 86 | 108 | 4 | GO:0001673 | |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | GTPBP4 SERBP1 CENPF SYNE1 SPTBN2 ARFGEF1 GBP2 DST PLEC DMD FKBP4 GOLGA1 SNX1 | 1.06e-03 | 934 | 108 | 13 | GO:0048471 |
| GeneOntologyCellularComponent | condensed chromosome | 1.08e-03 | 307 | 108 | 7 | GO:0000793 | |
| GeneOntologyCellularComponent | inner dynein arm | 1.16e-03 | 10 | 108 | 2 | GO:0036156 | |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | 1.30e-03 | 317 | 108 | 7 | GO:0032838 | |
| GeneOntologyCellularComponent | nuclear membrane protein complex | 1.41e-03 | 11 | 108 | 2 | GO:0106083 | |
| GeneOntologyCellularComponent | postsynaptic endosome membrane | 1.41e-03 | 11 | 108 | 2 | GO:0098895 | |
| GeneOntologyCellularComponent | nuclear membrane microtubule tethering complex | 1.41e-03 | 11 | 108 | 2 | GO:0106094 | |
| GeneOntologyCellularComponent | microtubule organizing center attachment site | 1.41e-03 | 11 | 108 | 2 | GO:0034992 | |
| GeneOntologyCellularComponent | hemidesmosome | 1.41e-03 | 11 | 108 | 2 | GO:0030056 | |
| GeneOntologyCellularComponent | meiotic nuclear membrane microtubule tethering complex | 1.41e-03 | 11 | 108 | 2 | GO:0034993 | |
| GeneOntologyCellularComponent | 9+2 motile cilium | 1.49e-03 | 238 | 108 | 6 | GO:0097729 | |
| GeneOntologyCellularComponent | centriole | 2.00e-03 | 172 | 108 | 5 | GO:0005814 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | KIF13B CFAP95 DNAH10 DYNC2H1 TUBGCP4 DNAH1 DST ASPM PLEC DMD FKBP4 PCNT | 2.34e-03 | 899 | 108 | 12 | GO:0099513 |
| GeneOntologyCellularComponent | dynein complex | 2.75e-03 | 54 | 108 | 3 | GO:0030286 | |
| GeneOntologyCellularComponent | germ cell nucleus | 2.82e-03 | 113 | 108 | 4 | GO:0043073 | |
| GeneOntologyCellularComponent | sarcoplasm | 2.91e-03 | 114 | 108 | 4 | GO:0016528 | |
| GeneOntologyCellularComponent | supramolecular fiber | KIF13B CFAP95 DNAH10 DYNC2H1 SYNE1 TUBGCP4 DNAH1 DST SYNE2 ASPM PLEC DMD FKBP4 PCNT | 2.99e-03 | 1179 | 108 | 14 | GO:0099512 |
| GeneOntologyCellularComponent | dense core granule | 3.05e-03 | 56 | 108 | 3 | GO:0031045 | |
| GeneOntologyCellularComponent | sarcolemma | 3.08e-03 | 190 | 108 | 5 | GO:0042383 | |
| GeneOntologyCellularComponent | supramolecular polymer | KIF13B CFAP95 DNAH10 DYNC2H1 SYNE1 TUBGCP4 DNAH1 DST SYNE2 ASPM PLEC DMD FKBP4 PCNT | 3.18e-03 | 1187 | 108 | 14 | GO:0099081 |
| GeneOntologyCellularComponent | ciliary basal body | 3.44e-03 | 195 | 108 | 5 | GO:0036064 | |
| GeneOntologyCellularComponent | neuronal cell body | GRIPAP1 MAOB SPTBN2 IREB2 NEO1 VPS13A UBXN2A DMD USH2A TOP1 FKBP4 | 3.94e-03 | 835 | 108 | 11 | GO:0043025 |
| GeneOntologyCellularComponent | somatodendritic compartment | GRIPAP1 MAOB SYNE1 SPTBN2 IREB2 NEO1 VPS13A UBXN2A PLEC DMD USH2A TOP1 FKBP4 SNX1 | 4.30e-03 | 1228 | 108 | 14 | GO:0036477 |
| GeneOntologyCellularComponent | dystrophin-associated glycoprotein complex | 4.73e-03 | 20 | 108 | 2 | GO:0016010 | |
| GeneOntologyCellularComponent | costamere | 5.71e-03 | 22 | 108 | 2 | GO:0043034 | |
| Domain | Spectrin_repeat | 4.68e-14 | 29 | 108 | 9 | IPR002017 | |
| Domain | Spectrin | 4.38e-13 | 23 | 108 | 8 | PF00435 | |
| Domain | SPEC | 9.01e-12 | 32 | 108 | 8 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 9.01e-12 | 32 | 108 | 8 | IPR018159 | |
| Domain | ACTININ_2 | 4.03e-11 | 23 | 108 | 7 | PS00020 | |
| Domain | ACTININ_1 | 4.03e-11 | 23 | 108 | 7 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 4.03e-11 | 23 | 108 | 7 | IPR001589 | |
| Domain | CH | 3.69e-09 | 65 | 108 | 8 | SM00033 | |
| Domain | CH | 6.74e-09 | 70 | 108 | 8 | PF00307 | |
| Domain | - | 7.56e-09 | 71 | 108 | 8 | 1.10.418.10 | |
| Domain | CH | 9.46e-09 | 73 | 108 | 8 | PS50021 | |
| Domain | CH-domain | 1.18e-08 | 75 | 108 | 8 | IPR001715 | |
| Domain | TPR_REGION | 5.21e-06 | 165 | 108 | 8 | PS50293 | |
| Domain | TPR | 5.21e-06 | 165 | 108 | 8 | PS50005 | |
| Domain | TPR-contain_dom | 2.65e-05 | 150 | 108 | 7 | IPR013026 | |
| Domain | Dystrophin | 3.31e-05 | 2 | 108 | 2 | IPR016344 | |
| Domain | Dynein_heavy_chain_D4_dom | 6.53e-05 | 14 | 108 | 3 | IPR024317 | |
| Domain | Dynein_HC_stalk | 6.53e-05 | 14 | 108 | 3 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 6.53e-05 | 14 | 108 | 3 | IPR013602 | |
| Domain | DHC_N2 | 6.53e-05 | 14 | 108 | 3 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 6.53e-05 | 14 | 108 | 3 | IPR011704 | |
| Domain | MT | 6.53e-05 | 14 | 108 | 3 | PF12777 | |
| Domain | AAA_8 | 6.53e-05 | 14 | 108 | 3 | PF12780 | |
| Domain | AAA_5 | 6.53e-05 | 14 | 108 | 3 | PF07728 | |
| Domain | DHC_fam | 8.13e-05 | 15 | 108 | 3 | IPR026983 | |
| Domain | Dynein_heavy | 8.13e-05 | 15 | 108 | 3 | PF03028 | |
| Domain | Dynein_heavy_dom | 8.13e-05 | 15 | 108 | 3 | IPR004273 | |
| Domain | VPS13 | 9.90e-05 | 3 | 108 | 2 | IPR026847 | |
| Domain | VPS13_mid_rpt | 9.90e-05 | 3 | 108 | 2 | PF16910 | |
| Domain | VPS13 | 9.90e-05 | 3 | 108 | 2 | PF16908 | |
| Domain | VPS13_N2 | 9.90e-05 | 3 | 108 | 2 | IPR031646 | |
| Domain | VPS13_mid_rpt | 9.90e-05 | 3 | 108 | 2 | IPR031642 | |
| Domain | TPR_repeat | 1.23e-04 | 133 | 108 | 6 | IPR019734 | |
| Domain | TPR_1 | 1.75e-04 | 90 | 108 | 5 | IPR001440 | |
| Domain | TPR_1 | 1.75e-04 | 90 | 108 | 5 | PF00515 | |
| Domain | KASH | 1.97e-04 | 4 | 108 | 2 | IPR012315 | |
| Domain | SHR-BD | 1.97e-04 | 4 | 108 | 2 | IPR009543 | |
| Domain | KASH | 1.97e-04 | 4 | 108 | 2 | PS51049 | |
| Domain | KASH | 1.97e-04 | 4 | 108 | 2 | SM01249 | |
| Domain | KASH | 1.97e-04 | 4 | 108 | 2 | PF10541 | |
| Domain | VPS13_C | 1.97e-04 | 4 | 108 | 2 | PF16909 | |
| Domain | VPS13_C | 1.97e-04 | 4 | 108 | 2 | IPR031645 | |
| Domain | SHR-BD | 1.97e-04 | 4 | 108 | 2 | PF06650 | |
| Domain | TPR_8 | 2.49e-04 | 53 | 108 | 4 | PF13181 | |
| Domain | Autophagy-rel_C | 3.28e-04 | 5 | 108 | 2 | IPR015412 | |
| Domain | ATG_C | 3.28e-04 | 5 | 108 | 2 | PF09333 | |
| Domain | P-loop_NTPase | KIF13B GTPBP4 DLG5 THNSL1 DNAH10 ABCA12 DYNC2H1 GBP2 RNF213 BTAF1 SMC2 DNAH1 HS2ST1 ASPM | 3.76e-04 | 848 | 108 | 14 | IPR027417 |
| Domain | - | 4.89e-04 | 6 | 108 | 2 | 3.90.1290.10 | |
| Domain | EF-hand_dom_typ1 | 4.89e-04 | 6 | 108 | 2 | IPR015153 | |
| Domain | EF-hand_dom_typ2 | 4.89e-04 | 6 | 108 | 2 | IPR015154 | |
| Domain | EF-hand_2 | 4.89e-04 | 6 | 108 | 2 | PF09068 | |
| Domain | EF-hand_3 | 4.89e-04 | 6 | 108 | 2 | PF09069 | |
| Domain | Plectin | 6.83e-04 | 7 | 108 | 2 | PF00681 | |
| Domain | Plectin_repeat | 6.83e-04 | 7 | 108 | 2 | IPR001101 | |
| Domain | PLEC | 6.83e-04 | 7 | 108 | 2 | SM00250 | |
| Domain | Chorein_N | 9.07e-04 | 8 | 108 | 2 | PF12624 | |
| Domain | DHC_N1 | 9.07e-04 | 8 | 108 | 2 | PF08385 | |
| Domain | VPS13_N | 9.07e-04 | 8 | 108 | 2 | IPR026854 | |
| Domain | Dynein_heavy_dom-1 | 9.07e-04 | 8 | 108 | 2 | IPR013594 | |
| Domain | TPR | 9.18e-04 | 129 | 108 | 5 | SM00028 | |
| Domain | - | GTPBP4 DLG5 THNSL1 DNAH10 ABCA12 DYNC2H1 GBP2 RNF213 BTAF1 SMC2 DNAH1 HS2ST1 | 1.26e-03 | 746 | 108 | 12 | 3.40.50.300 |
| Domain | - | 1.29e-03 | 207 | 108 | 6 | 1.25.40.10 | |
| Domain | CAP_GLY | 1.45e-03 | 10 | 108 | 2 | PF01302 | |
| Domain | CAP_GLY | 1.45e-03 | 10 | 108 | 2 | SM01052 | |
| Domain | - | 1.45e-03 | 10 | 108 | 2 | 2.30.30.190 | |
| Domain | CAP_GLY_1 | 1.45e-03 | 10 | 108 | 2 | PS00845 | |
| Domain | CAP_GLY_2 | 1.45e-03 | 10 | 108 | 2 | PS50245 | |
| Domain | CAP-Gly_domain | 1.45e-03 | 10 | 108 | 2 | IPR000938 | |
| Domain | Elongated_TPR_rpt_dom | 1.76e-03 | 11 | 108 | 2 | IPR023114 | |
| Domain | Ferric_reduct | 2.11e-03 | 12 | 108 | 2 | PF01794 | |
| Domain | Fe3_Rdtase_TM_dom | 2.11e-03 | 12 | 108 | 2 | IPR013130 | |
| Domain | TPR-like_helical_dom | 2.35e-03 | 233 | 108 | 6 | IPR011990 | |
| Domain | Spectrin_alpha_SH3 | 3.31e-03 | 15 | 108 | 2 | IPR013315 | |
| Domain | FKBP_PPIASE | 3.77e-03 | 16 | 108 | 2 | PS50059 | |
| Domain | FKBP_C | 3.77e-03 | 16 | 108 | 2 | PF00254 | |
| Domain | PPIase_FKBP | 4.26e-03 | 17 | 108 | 2 | IPR023566 | |
| Domain | ZF_ZZ_2 | 4.77e-03 | 18 | 108 | 2 | PS50135 | |
| Domain | ZF_ZZ_1 | 4.77e-03 | 18 | 108 | 2 | PS01357 | |
| Domain | ZZ | 4.77e-03 | 18 | 108 | 2 | PF00569 | |
| Domain | Znf_ZZ | 5.31e-03 | 19 | 108 | 2 | IPR000433 | |
| Domain | ZnF_ZZ | 5.31e-03 | 19 | 108 | 2 | SM00291 | |
| Pubmed | GTPBP4 DLG5 FAM184A WDR36 RPAP3 DYNC2H1 PPFIBP1 SYNE1 SPTBN2 IKBIP RRP1 KIAA0753 GTF2A1 TXLNA NEO1 FAM193A P4HA1 SYNE2 VPS13A ASPM FKBP4 FKBP5 SNX1 PPP6R3 PCNT | 5.36e-12 | 1487 | 110 | 25 | 33957083 | |
| Pubmed | DLG5 DNAH10 DYNC2H1 SYNE1 SPTA1 RNF213 DST SYNE2 PLEC DMD PCNT | 2.17e-11 | 187 | 110 | 11 | 26460568 | |
| Pubmed | GTPBP4 SERBP1 WDR36 WARS1 CENPF SPTBN2 RRP1 DST SYNE2 NUFIP2 SMARCC1 PLEC UTRN TOP1 FKBP4 PPP6R3 PCNT | 2.79e-11 | 653 | 110 | 17 | 22586326 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | GTPBP4 CACNA2D1 WDR36 CENPF SYNE1 SPTBN2 BTAF1 SMC2 RRP1 CEP350 DST SYNE2 LMAN2 PLEC UTRN TOP1 FKBP4 TOP2A CDC23 PCNT | 7.17e-11 | 1024 | 110 | 20 | 24711643 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | GTPBP4 SERBP1 WDR36 WARS1 RPAP3 BTAF1 GTF2A1 DST FAM193A RBM27 NUFIP2 NCOA7 UTRN TOP1 FKBP4 TOP2A SNX1 PPP6R3 PCNT | 1.15e-10 | 934 | 110 | 19 | 33916271 |
| Pubmed | Charting the landscape of tandem BRCT domain-mediated protein interactions. | RPGRIP1 SERBP1 WARS1 RPAP3 DYNC2H1 SYCP3 SMC2 RRP1 CEP350 RNF14 ASPM FLCN USH2A CDC23 PPP6R3 PCNT | 3.94e-10 | 670 | 110 | 16 | 22990118 |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | DLG5 FAM184A GRIPAP1 SERBP1 RPAP3 PPFIBP1 VPS13C SPTBN2 CEP350 TXLNA ITSN2 PLEC PDZRN3 FKBP4 TOP2A PPP6R3 PCNT | 1.65e-09 | 853 | 110 | 17 | 28718761 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | GTPBP4 DLG5 SERBP1 WDR36 NOP16 CENPF RPAP3 PPFIBP1 SPTBN2 SMC2 IKBIP RRP1 TXLNA DST RBM27 NUFIP2 PLEC TOP1 FKBP4 TOP2A | 2.49e-09 | 1257 | 110 | 20 | 36526897 |
| Pubmed | KIF13B GTPBP4 CACNA2D1 CENPF DOCK11 SYNE1 SPTBN2 SMC2 TXLNA DST TAX1BP1 SYNE2 NUFIP2 SMARCC1 GOLGA1 UNC13A PCNT | 9.94e-09 | 963 | 110 | 17 | 28671696 | |
| Pubmed | 3.07e-08 | 11 | 110 | 4 | 22826121 | ||
| Pubmed | 6.24e-08 | 234 | 110 | 9 | 36243803 | ||
| Pubmed | 1.23e-07 | 4 | 110 | 3 | 17389230 | ||
| Pubmed | KIF13B RPGRIP1 CENPF CTDSPL2 SYNE1 SPTA1 SPTBN2 SMC2 DST SYNE2 ITSN2 VPS13A ASPM SMARCC1 PLEC DMD TOP1 TOP2A PCNT | 1.29e-07 | 1442 | 110 | 19 | 35575683 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | GTPBP4 SERBP1 WDR36 CENPF SMC2 RRP1 TXLNA RBM27 CENPH HS2ST1 NUFIP2 ASPM TOP1 TOP2A | 1.31e-07 | 759 | 110 | 14 | 35915203 |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 1.34e-07 | 256 | 110 | 9 | 33397691 | |
| Pubmed | SERBP1 RPAP3 SPTBN2 SMC2 RBM27 NUFIP2 SMARCC1 AMOTL2 TOP2A SNX1 CDC23 PPP6R3 | 1.84e-07 | 549 | 110 | 12 | 38280479 | |
| Pubmed | RPAP3 CTDSPL2 SPTBN2 RNF213 KIAA0753 CEP350 P4HA1 SYNE2 NUFIP2 VPS13A DMD UTRN FKBP4 FKBP5 PPP6R3 PCNT | 2.06e-07 | 1049 | 110 | 16 | 27880917 | |
| Pubmed | The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1. | 2.30e-07 | 197 | 110 | 8 | 20811636 | |
| Pubmed | GTPBP4 DLG5 SERBP1 WDR36 NOP16 SPTBN2 IREB2 IKBIP RRP1 CEP350 TXLNA RBM27 P4HA1 TAX1BP1 NUFIP2 SMARCC1 PLEC TOP1 | 3.03e-07 | 1371 | 110 | 18 | 36244648 | |
| Pubmed | ATG5 is required for B cell polarization and presentation of particulate antigens. | CWF19L2 SERBP1 WARS1 SMC2 RRP1 TXLNA RBM27 ITSN2 NUFIP2 SMARCC1 PLEC TOP1 TOP2A | 3.59e-07 | 701 | 110 | 13 | 30196744 |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | KIF13B CWF19L2 DLG5 GRIPAP1 OTUD5 DYNC2H1 CENPH ASPM FKBP5 CDC23 PPP6R3 PCNT | 3.81e-07 | 588 | 110 | 12 | 38580884 |
| Pubmed | GTPBP4 DLG5 SERBP1 NOP16 TUBGCP4 SMC2 RRP1 DNAH1 TAX1BP1 NUFIP2 SMARCC1 AMOTL2 TOP1 FKBP4 FKBP5 TOP2A PPP6R3 | 3.99e-07 | 1247 | 110 | 17 | 27684187 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | SERBP1 WARS1 RPAP3 DOCK11 CEP350 TXLNA FAM193A RBM27 SYTL4 NUFIP2 SMARCC1 PLEC TOP1 | 5.16e-07 | 724 | 110 | 13 | 36232890 |
| Pubmed | 5.54e-07 | 151 | 110 | 7 | 17043677 | ||
| Pubmed | GRIPAP1 RPAP3 VPS13C RNF213 CEP350 NEO1 FAM193A SYTL4 P4HA1 NUFIP2 C6orf47 PDZRN3 FKBP5 | 5.92e-07 | 733 | 110 | 13 | 34672954 | |
| Pubmed | 6.11e-07 | 6 | 110 | 3 | 18827015 | ||
| Pubmed | GTPBP4 CACNA2D1 SERBP1 WDR36 NOP16 PPFIBP1 SPTBN2 RNF213 BTAF1 TUBGCP4 SMC2 RRP1 DST SYNE2 LMAN2 FKBP5 TOP2A PPP6R3 | 6.17e-07 | 1440 | 110 | 18 | 30833792 | |
| Pubmed | GRIPAP1 PPFIBP1 VPS13C ARFGEF1 NEO1 DST SYNE2 VPS13A FLCN ADAM17 SNX1 | 6.23e-07 | 504 | 110 | 11 | 34432599 | |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | KIF13B THNSL1 WDR36 OTUD5 DYNC2H1 E2F5 USP26 USP38 SYTL4 NUFIP2 UBXN2A PLEC UTRN FKBP5 PPP6R3 | 6.72e-07 | 1005 | 110 | 15 | 19615732 |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | KIF13B RPGRIP1 GRIPAP1 RPAP3 DYNC2H1 PPFIBP1 E2F5 TUBGCP4 SMC2 IKBIP TXLNA SLC9C1 CENPH NUFIP2 PLEC STEAP1 CDC23 | 8.84e-07 | 1321 | 110 | 17 | 27173435 |
| Pubmed | DLG5 RRP1 KIAA0753 CEP350 TXLNA DST RBM27 TAX1BP1 NUFIP2 UTRN SNX1 PCNT | 1.01e-06 | 645 | 110 | 12 | 25281560 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | GTPBP4 THNSL1 WDR36 CENPF RPAP3 VPS13C SYNE1 RNF213 RRP1 DST SYNE2 ITSN2 VPS13A TOP1 FKBP4 TOP2A CDC23 PCNT | 1.07e-06 | 1496 | 110 | 18 | 32877691 |
| Pubmed | NOP16 RPAP3 RRP1 CEP350 DST RBM27 SYTL4 TOP1 FKBP4 FKBP5 PPP6R3 | 1.38e-06 | 547 | 110 | 11 | 37267103 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | GTPBP4 DLG5 SERBP1 WDR36 NOP16 SYNE1 SPTBN2 RRP1 DST TAX1BP1 NUFIP2 PLEC TOP1 TOP2A | 1.87e-06 | 949 | 110 | 14 | 36574265 |
| Pubmed | 2.16e-06 | 118 | 110 | 6 | 30979931 | ||
| Pubmed | 2.44e-06 | 30 | 110 | 4 | 30480076 | ||
| Pubmed | GTPBP4 SERBP1 WDR36 BTAF1 SMC2 TXLNA NUFIP2 ASPM SMARCC1 LMAN2 TOP1 FKBP5 CDC23 PPP6R3 | 2.44e-06 | 971 | 110 | 14 | 33306668 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | GTPBP4 SERBP1 WDR36 WARS1 DNAH10 CENPF DYNC2H1 VPS13C SYNE1 SMC2 RRP1 TXLNA SMARCC1 LMAN2 TOP1 FKBP4 TOP2A | 2.47e-06 | 1425 | 110 | 17 | 30948266 |
| Pubmed | SERBP1 WDR36 SYNE1 RNF213 TTBK2 DST PLEC DMD UTRN TOP1 FKBP4 TOP2A SNX1 | 2.81e-06 | 844 | 110 | 13 | 25963833 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | GTPBP4 GRIPAP1 SERBP1 SPTBN2 SMC2 IKBIP TXLNA SMARCC1 PLEC UTRN TOP1 FKBP4 PCNT | 2.92e-06 | 847 | 110 | 13 | 35235311 |
| Pubmed | 3.19e-06 | 481 | 110 | 10 | 28190767 | ||
| Pubmed | WARS1 NOP16 OTUD5 VPS13C IREB2 IKBIP TXLNA RBM27 P4HA1 CENPH SYNE2 ITSN2 FKBP5 SNX1 | 3.71e-06 | 1007 | 110 | 14 | 34597346 | |
| Pubmed | GTPBP4 SERBP1 WDR36 RNF213 SMC2 RBM27 CENPH SMARCC1 PLEC TOP1 FKBP4 FKBP5 TOP2A CDC23 | 4.01e-06 | 1014 | 110 | 14 | 32416067 | |
| Pubmed | KIAA0408 SYNE1 CCDC141 NEO1 DST P4HA1 TAX1BP1 SYNE2 PLEC UTRN | 4.25e-06 | 497 | 110 | 10 | 23414517 | |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | 4.33e-06 | 498 | 110 | 10 | 36634849 | |
| Pubmed | 4.82e-06 | 209 | 110 | 7 | 36779422 | ||
| Pubmed | 4.98e-06 | 210 | 110 | 7 | 16565220 | ||
| Pubmed | GTPBP4 SERBP1 WARS1 DYNC2H1 VPS13C SYNE1 GBP2 SYNE2 NUFIP2 SMARCC1 DMD SNX1 | 5.00e-06 | 754 | 110 | 12 | 35906200 | |
| Pubmed | 5.63e-06 | 214 | 110 | 7 | 22199357 | ||
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | DLG5 GRIPAP1 WDR36 NAGA ARFGEF1 RNF213 SMC2 IKBIP RRP1 P4HA1 SYNE2 SMARCC1 UTRN FKBP4 TOP2A SNX1 | 6.40e-06 | 1367 | 110 | 16 | 32687490 |
| Pubmed | Proximity Mapping of CCP6 Reveals Its Association with Centrosome Organization and Cilium Assembly. | 6.44e-06 | 38 | 110 | 4 | 36674791 | |
| Pubmed | GRIPAP1 WDR36 PPFIBP1 VPS13C ARFGEF1 RNF213 CEP350 NEO1 DST SYTL4 VPS13A SNX1 | 6.77e-06 | 777 | 110 | 12 | 35844135 | |
| Pubmed | 8.49e-06 | 538 | 110 | 10 | 28524877 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 10525423 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 20434517 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 22768332 | ||
| Pubmed | Plasma lipidomic analysis shows a disease progression signature in mdx mice. | 9.91e-06 | 2 | 110 | 2 | 34155298 | |
| Pubmed | In Vivo Genome Editing Restores Dystrophin Expression and Cardiac Function in Dystrophic Mice. | 9.91e-06 | 2 | 110 | 2 | 28790199 | |
| Pubmed | Dystrophic changes in extraocular muscles after gamma irradiation in mdx:utrophin(+/-) mice. | 9.91e-06 | 2 | 110 | 2 | 24466085 | |
| Pubmed | E2F5 and LEK1 translocation to the nucleus is an early event demarcating myoblast quiescence. | 9.91e-06 | 2 | 110 | 2 | 17295207 | |
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 27110493 | ||
| Pubmed | Rapid depletion of muscle progenitor cells in dystrophic mdx/utrophin-/- mice. | 9.91e-06 | 2 | 110 | 2 | 24781208 | |
| Pubmed | Isolation and characterization of a genomic clone from the murine utrophin locus. | 9.91e-06 | 2 | 110 | 2 | 8268660 | |
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 25859846 | ||
| Pubmed | A new anti-depressive strategy for the elderly: ablation of FKBP5/FKBP51. | 9.91e-06 | 2 | 110 | 2 | 21935478 | |
| Pubmed | G-utrophin, the autosomal homologue of dystrophin Dp116, is expressed in sensory ganglia and brain. | 9.91e-06 | 2 | 110 | 2 | 7731967 | |
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 27037492 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 16710609 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 10852813 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 16487708 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 30672725 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 20796173 | ||
| Pubmed | Voltage-gated ion channel dysfunction precedes cardiomyopathy development in the dystrophic heart. | 9.91e-06 | 2 | 110 | 2 | 21677768 | |
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 7962191 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 9713852 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 11792814 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 25607927 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 8021701 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 25777966 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 26974331 | ||
| Pubmed | Developmental studies of dystrophin-positive fibers in mdx, and DRP localization. | 9.91e-06 | 2 | 110 | 2 | 8433092 | |
| Pubmed | Second-generation compound for the modulation of utrophin in the therapy of DMD. | 9.91e-06 | 2 | 110 | 2 | 25935002 | |
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 16024571 | ||
| Pubmed | TOP2A and CENPF are synergistic master regulators activated in cervical cancer. | 9.91e-06 | 2 | 110 | 2 | 33023625 | |
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 28453658 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 24130054 | ||
| Pubmed | A quantitative study of bioenergetics in skeletal muscle lacking utrophin and dystrophin. | 9.91e-06 | 2 | 110 | 2 | 11801396 | |
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 7987307 | ||
| Pubmed | Utility of dystrophin and utrophin staining in childhood muscular dystrophy. | 9.91e-06 | 2 | 110 | 2 | 16295426 | |
| Pubmed | Nesprin-1 and nesprin-2 regulate endothelial cell shape and migration. | 9.91e-06 | 2 | 110 | 2 | 24931616 | |
| Pubmed | Comparative analysis of the human dystrophin and utrophin gene structures. | 9.91e-06 | 2 | 110 | 2 | 11861579 | |
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 24749623 | ||
| Pubmed | Distinct mechanical properties in homologous spectrin-like repeats of utrophin. | 9.91e-06 | 2 | 110 | 2 | 30914715 | |
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 19651889 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 9590295 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 22284942 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 29879154 | ||
| Pubmed | Haploinsufficiency of utrophin gene worsens skeletal muscle inflammation and fibrosis in mdx mice. | 9.91e-06 | 2 | 110 | 2 | 17889902 | |
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 12370193 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 32025735 | ||
| Interaction | ATG16L1 interactions | DENND5B CWF19L2 DLG5 GRIPAP1 SERBP1 WARS1 VPS13C SMC2 IKBIP RRP1 KIAA0753 CEP350 TXLNA FAM193A RBM27 CENPH ITSN2 NUFIP2 SMARCC1 AKAP10 PLEC TOP1 TOP2A | 2.82e-08 | 1161 | 106 | 23 | int:ATG16L1 |
| Interaction | DISC1 interactions | CWF19L2 GRIPAP1 SYNE1 SMC2 CCDC141 IKBIP CEP350 DST DMD UTRN TOP1 CDC23 PPP6R3 PCNT | 5.65e-08 | 429 | 106 | 14 | int:DISC1 |
| Interaction | PCNT interactions | FAM184A SYNE1 SPTBN2 IKBIP KIAA0753 CEP350 DST PLEC UTRN GOLGA1 PCNT | 5.83e-08 | 241 | 106 | 11 | int:PCNT |
| Interaction | SIRT7 interactions | GTPBP4 SERBP1 WDR36 WARS1 CENPF SPTBN2 RRP1 DST SYNE2 NUFIP2 SMARCC1 PLEC UTRN TOP1 FKBP4 TOP2A PPP6R3 PCNT | 6.07e-08 | 744 | 106 | 18 | int:SIRT7 |
| Interaction | NDC80 interactions | DLG5 KIAA0753 CEP350 TXLNA RBM27 CENPH SYNE2 NUFIP2 ASPM AMOTL2 TOP1 PCNT | 9.22e-08 | 312 | 106 | 12 | int:NDC80 |
| Interaction | GAN interactions | DLG5 DNAH10 DYNC2H1 SYNE1 SPTA1 RNF213 DST SYNE2 PLEC DMD PCNT | 9.55e-08 | 253 | 106 | 11 | int:GAN |
| Interaction | SYNE3 interactions | DLG5 VPS13C IKBIP KIAA0753 CEP350 DST FAM193A P4HA1 SYNE2 LMAN2 PLEC CDC23 PCNT | 6.00e-07 | 444 | 106 | 13 | int:SYNE3 |
| Interaction | MED4 interactions | DLG5 FAM184A RRP1 KIAA0753 CEP350 TXLNA DST RBM27 TAX1BP1 NUFIP2 UTRN SNX1 PCNT | 6.97e-07 | 450 | 106 | 13 | int:MED4 |
| Interaction | NAA40 interactions | GTPBP4 SERBP1 WDR36 WARS1 RPAP3 BTAF1 GTF2A1 DST FAM193A RBM27 NUFIP2 NCOA7 UTRN TOP1 FKBP4 TOP2A SNX1 PPP6R3 PCNT | 7.39e-07 | 978 | 106 | 19 | int:NAA40 |
| Interaction | PIBF1 interactions | CWF19L2 FAM184A GRIPAP1 KIAA0753 TXLNA TAX1BP1 AMOTL2 GOLGA1 PCNT | 1.12e-06 | 200 | 106 | 9 | int:PIBF1 |
| Interaction | PHLPP1 interactions | DLG5 WARS1 CENPF RPAP3 RBM27 NUFIP2 ASPM PLEC FKBP4 FKBP5 SNX1 | 1.46e-06 | 333 | 106 | 11 | int:PHLPP1 |
| Interaction | KDM1A interactions | KIAA0408 DLG5 GRIPAP1 CENPF RPAP3 IKBIP CEP350 DST FAM193A USP38 ITSN2 SMARCC1 PLEC UTRN FKBP4 CDC23 PPP6R3 PCNT | 1.88e-06 | 941 | 106 | 18 | int:KDM1A |
| Interaction | EPHA1 interactions | 4.21e-06 | 235 | 106 | 9 | int:EPHA1 | |
| Interaction | AP2B1 interactions | KIAA0408 DLG5 SERBP1 TUBGCP4 CEP350 FAM193A ITSN2 FKBP5 CDC23 PPP6R3 PCNT | 4.35e-06 | 373 | 106 | 11 | int:AP2B1 |
| Interaction | NINL interactions | DLG5 FAM184A DYNC2H1 TUBGCP4 SMC2 KIAA0753 DNAH1 CEP350 TXLNA ITSN2 TOP2A PCNT | 5.24e-06 | 458 | 106 | 12 | int:NINL |
| Interaction | LAMTOR1 interactions | DENND5B KIF13B GRIPAP1 PPFIBP1 VPS13C SPTBN2 ARFGEF1 DST NUFIP2 FLCN NCOA7 AKAP10 DMD FKBP4 SNX1 | 5.59e-06 | 722 | 106 | 15 | int:LAMTOR1 |
| Interaction | STIL interactions | 7.38e-06 | 190 | 106 | 8 | int:STIL | |
| Interaction | RAB35 interactions | DENND5B DLG5 GRIPAP1 SERBP1 PPFIBP1 VPS13C SPTBN2 DST SYNE2 VPS13A FLCN NCOA7 UTRN | 9.82e-06 | 573 | 106 | 13 | int:RAB35 |
| Interaction | SEPTIN10 interactions | 1.11e-05 | 144 | 106 | 7 | int:SEPTIN10 | |
| Interaction | CSPP1 interactions | 1.16e-05 | 96 | 106 | 6 | int:CSPP1 | |
| Interaction | TERF2 interactions | 1.24e-05 | 340 | 106 | 10 | int:TERF2 | |
| Interaction | RAB9A interactions | GTPBP4 GRIPAP1 NOP16 PPFIBP1 VPS13C ARFGEF1 DST SYNE2 VPS13A FLCN NCOA7 AKAP10 SNX1 | 1.46e-05 | 595 | 106 | 13 | int:RAB9A |
| Interaction | OFD1 interactions | RPGRIP1 FAM184A RPAP3 KIAA0753 CEP350 TXLNA PDZRN3 FKBP4 GOLGA1 PCNT | 1.48e-05 | 347 | 106 | 10 | int:OFD1 |
| Interaction | STX4 interactions | DLG5 GRIPAP1 CENPF PPFIBP1 SYNE1 TXLNA NEO1 SYNE2 ITSN2 VPS13A UTRN | 1.59e-05 | 428 | 106 | 11 | int:STX4 |
| Interaction | ODAD1 interactions | 1.59e-05 | 60 | 106 | 5 | int:ODAD1 | |
| Interaction | OBSL1 interactions | GTPBP4 WDR36 CENPF PPFIBP1 SYNE1 SPTBN2 RRP1 DNAH1 SLC9C1 DST SYNE2 PLEC UTRN TOP1 TOP2A PCNT | 1.91e-05 | 902 | 106 | 16 | int:OBSL1 |
| Interaction | LMAN2 interactions | 1.94e-05 | 105 | 106 | 6 | int:LMAN2 | |
| Interaction | KRT8 interactions | DLG5 GRIPAP1 ARFGEF1 KIAA0753 CEP350 FAM193A PLEC DMD PDZRN3 FKBP4 PCNT | 2.09e-05 | 441 | 106 | 11 | int:KRT8 |
| Interaction | RAB11A interactions | DENND5B KIF13B GTPBP4 CACNA2D1 GRIPAP1 NOP16 PPFIBP1 VPS13C ARFGEF1 DST SYTL4 SYNE2 VPS13A AKAP10 SNX1 | 2.89e-05 | 830 | 106 | 15 | int:RAB11A |
| Interaction | RAB4A interactions | KIF13B GRIPAP1 VPS13C SYNE1 ARFGEF1 DST SYNE2 VPS13A NCOA7 AKAP10 SNX1 | 2.90e-05 | 457 | 106 | 11 | int:RAB4A |
| Interaction | ANAPC2 interactions | 3.32e-05 | 234 | 106 | 8 | int:ANAPC2 | |
| Interaction | PPP1CB interactions | GRIPAP1 SERBP1 RPAP3 SPTBN2 RNF213 CSRNP1 DST UBXN2A PLEC TOP1 SNX1 | 3.67e-05 | 469 | 106 | 11 | int:PPP1CB |
| Interaction | CEP152 interactions | 4.51e-05 | 179 | 106 | 7 | int:CEP152 | |
| Interaction | CEP63 interactions | 4.51e-05 | 179 | 106 | 7 | int:CEP63 | |
| Interaction | GOLGA1 interactions | 5.19e-05 | 183 | 106 | 7 | int:GOLGA1 | |
| Interaction | CIT interactions | GTPBP4 SERBP1 WDR36 NOP16 CENPF RPAP3 DYNC2H1 SYNE1 SPTBN2 RNF213 SEC31B OR4C15 RBM27 P4HA1 SYNE2 NUFIP2 SMARCC1 PLEC TOP1 TOP2A | 6.00e-05 | 1450 | 106 | 20 | int:CIT |
| Interaction | TNIP1 interactions | GTPBP4 DLG5 SERBP1 WDR36 NOP16 SYNE1 SPTBN2 IKBIP RRP1 TXLNA DST TAX1BP1 NUFIP2 PLEC DMD TOP1 TOP2A CDC23 | 6.11e-05 | 1217 | 106 | 18 | int:TNIP1 |
| Interaction | ECT2 interactions | GTPBP4 CWF19L2 SERBP1 WDR36 VPS13C SPTBN2 RNF14 DST P4HA1 NUFIP2 ASPM PLEC TOP1 TOP2A PPP6R3 | 6.16e-05 | 887 | 106 | 15 | int:ECT2 |
| Interaction | TRIM52 interactions | 7.33e-05 | 133 | 106 | 6 | int:TRIM52 | |
| Interaction | BRCA1 interactions | RPGRIP1 CWF19L2 FAM184A CENPF RPAP3 ARFGEF1 SYCP3 CEP350 TXLNA DST NUFIP2 SMARCC1 PLEC USH2A TOP1 FKBP4 TOP2A PPP6R3 | 8.52e-05 | 1249 | 106 | 18 | int:BRCA1 |
| Interaction | HSF1 interactions | DENND5B GTPBP4 SERBP1 LURAP1L SYNE2 NUFIP2 TOP1 PDZRN3 FKBP4 FKBP5 TOP2A SNX1 | 8.61e-05 | 609 | 106 | 12 | int:HSF1 |
| Interaction | VPS33B interactions | 8.79e-05 | 199 | 106 | 7 | int:VPS33B | |
| Interaction | IFI16 interactions | GTPBP4 SERBP1 WDR36 NOP16 SYNE1 RNF213 RRP1 NUFIP2 ASPM SMARCC1 TOP1 FKBP4 TOP2A | 9.54e-05 | 714 | 106 | 13 | int:IFI16 |
| Interaction | PCM1 interactions | RPGRIP1 DLG5 FAM184A KIAA0753 CEP350 TXLNA TAX1BP1 PDZRN3 GOLGA1 PCNT | 9.77e-05 | 434 | 106 | 10 | int:PCM1 |
| Interaction | DCTN2 interactions | 1.10e-04 | 356 | 106 | 9 | int:DCTN2 | |
| Interaction | LMAN1 interactions | SERBP1 RPAP3 PPFIBP1 VPS13C SPTBN2 DST SYNE2 VPS13A UBXN2A FKBP4 | 1.11e-04 | 441 | 106 | 10 | int:LMAN1 |
| Interaction | FGFR1 interactions | DLG5 GRIPAP1 PPFIBP1 SMC2 P4HA1 ITSN2 NUFIP2 NCOA7 LMAN2 PLEC UTRN SNX1 | 1.22e-04 | 632 | 106 | 12 | int:FGFR1 |
| Interaction | POLR3K interactions | 1.25e-04 | 92 | 106 | 5 | int:POLR3K | |
| Interaction | RDX interactions | 1.29e-04 | 284 | 106 | 8 | int:RDX | |
| Interaction | SASH1 interactions | 1.38e-04 | 50 | 106 | 4 | int:SASH1 | |
| Interaction | CDC37 interactions | GRIPAP1 SERBP1 RPAP3 SYCP3 TXLNA SYNE2 FLCN AMOTL2 FKBP4 FKBP5 TOP2A PPP6R3 | 1.48e-04 | 645 | 106 | 12 | int:CDC37 |
| Interaction | STEAP1B interactions | 1.63e-04 | 4 | 106 | 2 | int:STEAP1B | |
| Interaction | CCDC8 interactions | CACNA2D1 SPTBN2 BTAF1 SMC2 CEP350 DST LMAN2 PLEC UTRN TOP2A CDC23 PCNT | 1.73e-04 | 656 | 106 | 12 | int:CCDC8 |
| Interaction | NR3C1 interactions | SERBP1 DYNC2H1 SEC31B CEP350 RNF14 TTBK2 P4HA1 SYNE2 ITSN2 VPS13A SMARCC1 FLCN TOP1 FKBP4 FKBP5 | 1.74e-04 | 974 | 106 | 15 | int:NR3C1 |
| Interaction | AURKB interactions | GTPBP4 DLG5 SERBP1 RPAP3 RNF213 TAX1BP1 NUFIP2 SMARCC1 PLEC UTRN FKBP5 TOP2A PPP6R3 | 1.79e-04 | 761 | 106 | 13 | int:AURKB |
| Interaction | TNIK interactions | 1.84e-04 | 381 | 106 | 9 | int:TNIK | |
| Interaction | HECTD1 interactions | GTPBP4 SERBP1 WDR36 CENPF SMC2 RRP1 TXLNA RBM27 CENPH HS2ST1 NUFIP2 ASPM UTRN TOP1 TOP2A | 1.94e-04 | 984 | 106 | 15 | int:HECTD1 |
| Interaction | PPIA interactions | DLG5 SERBP1 WDR36 WARS1 CENPF DYNC2H1 SMC2 SEC31B GTF2A1 DST ASPM DMD TOP2A PPP6R3 | 2.29e-04 | 888 | 106 | 14 | int:PPIA |
| Interaction | CENPE interactions | 2.43e-04 | 106 | 106 | 5 | int:CENPE | |
| Interaction | AMOT interactions | 2.45e-04 | 312 | 106 | 8 | int:AMOT | |
| Interaction | FBXL6 interactions | NOP16 RPAP3 RRP1 CEP350 DST RBM27 SYTL4 TOP1 FKBP4 FKBP5 PPP6R3 | 2.51e-04 | 583 | 106 | 11 | int:FBXL6 |
| Interaction | SCN7A interactions | 2.71e-04 | 5 | 106 | 2 | int:SCN7A | |
| Interaction | RCOR1 interactions | GRIPAP1 CENPF SMC2 DST FAM193A SMARCC1 PLEC UTRN CDC23 PPP6R3 | 2.78e-04 | 494 | 106 | 10 | int:RCOR1 |
| Interaction | KIF23 interactions | KIF13B GTPBP4 DLG5 SERBP1 WDR36 NOP16 SMC2 TXLNA TAX1BP1 NUFIP2 ASPM PLEC DMD TOP1 TOP2A | 3.20e-04 | 1031 | 106 | 15 | int:KIF23 |
| Interaction | LAMP2 interactions | GRIPAP1 PPFIBP1 VPS13C SPTBN2 ARFGEF1 DST TAX1BP1 SYNE2 NCOA7 AKAP10 SNX1 | 3.63e-04 | 609 | 106 | 11 | int:LAMP2 |
| Interaction | H2BC5 interactions | 3.63e-04 | 331 | 106 | 8 | int:H2BC5 | |
| Interaction | TBC1D1 interactions | 3.83e-04 | 65 | 106 | 4 | int:TBC1D1 | |
| Interaction | MECP2 interactions | GTPBP4 CWF19L2 DLG5 WDR36 NOP16 SYNE1 SPTBN2 RRP1 DST RBM27 P4HA1 NUFIP2 SMARCC1 PLEC TOP1 UNC13A SNX1 | 3.83e-04 | 1287 | 106 | 17 | int:MECP2 |
| Interaction | WWTR1 interactions | 3.89e-04 | 422 | 106 | 9 | int:WWTR1 | |
| Interaction | KIF20A interactions | GTPBP4 SERBP1 WDR36 DYNC2H1 PPFIBP1 SYNE1 SPTBN2 SEC31B P4HA1 SYNE2 NUFIP2 PLEC UTRN TOP1 TOP2A | 3.96e-04 | 1052 | 106 | 15 | int:KIF20A |
| Interaction | PSKH2 interactions | 4.30e-04 | 67 | 106 | 4 | int:PSKH2 | |
| Interaction | LZTS1 interactions | 4.32e-04 | 120 | 106 | 5 | int:LZTS1 | |
| Interaction | STARD13 interactions | 4.55e-04 | 68 | 106 | 4 | int:STARD13 | |
| Interaction | PHF21A interactions | 4.60e-04 | 343 | 106 | 8 | int:PHF21A | |
| Interaction | ATG5 interactions | 4.69e-04 | 344 | 106 | 8 | int:ATG5 | |
| Interaction | SIRT6 interactions | GTPBP4 WDR36 DOCK11 SMC2 TXLNA RBM27 NUFIP2 SMARCC1 TOP2A CDC23 PPP6R3 | 4.70e-04 | 628 | 106 | 11 | int:SIRT6 |
| Interaction | USP7 interactions | KIAA0408 GTPBP4 CACNA2D1 SERBP1 SYNE1 CCDC141 DST ASPM SMARCC1 FLCN PLEC DMD UBE2QL1 UTRN FKBP5 TOP2A PPP6R3 | 4.82e-04 | 1313 | 106 | 17 | int:USP7 |
| Interaction | TRIM37 interactions | KIAA0408 RPGRIP1 CWF19L2 DLG5 SERBP1 KIAA0753 CEP350 FAM193A RBM27 SYTL4 PLEC | 4.83e-04 | 630 | 106 | 11 | int:TRIM37 |
| Interaction | DYNLL2 interactions | 4.84e-04 | 263 | 106 | 7 | int:DYNLL2 | |
| Interaction | CCDC138 interactions | 4.84e-04 | 123 | 106 | 5 | int:CCDC138 | |
| Interaction | TERF1 interactions | 4.97e-04 | 347 | 106 | 8 | int:TERF1 | |
| Interaction | AGBL4 interactions | 5.08e-04 | 70 | 106 | 4 | int:AGBL4 | |
| Interaction | LATS1 interactions | 5.26e-04 | 440 | 106 | 9 | int:LATS1 | |
| Interaction | RHOQ interactions | 5.44e-04 | 442 | 106 | 9 | int:RHOQ | |
| Interaction | CDC5L interactions | CWF19L2 SYNE1 BTAF1 TUBGCP4 SMC2 TXLNA DST PLEC TOP1 TOP2A CDC23 PPP6R3 PCNT | 5.47e-04 | 855 | 106 | 13 | int:CDC5L |
| Interaction | CNTRL interactions | 5.51e-04 | 193 | 106 | 6 | int:CNTRL | |
| Interaction | FAM184A interactions | 5.65e-04 | 72 | 106 | 4 | int:FAM184A | |
| Interaction | PON3 interactions | 5.66e-04 | 7 | 106 | 2 | int:PON3 | |
| Interaction | CFAP53 interactions | 5.71e-04 | 31 | 106 | 3 | int:CFAP53 | |
| Interaction | UBC interactions | 5.80e-04 | 446 | 106 | 9 | int:UBC | |
| Interaction | OGA interactions | 6.01e-04 | 129 | 106 | 5 | int:OGA | |
| Interaction | ACTR1A interactions | 6.17e-04 | 274 | 106 | 7 | int:ACTR1A | |
| Interaction | GSK3B interactions | DLG5 PPFIBP1 GBP2 CEP350 DST FAM193A LMAN2 PLEC UTRN FKBP4 FKBP5 TOP2A PPP6R3 | 6.30e-04 | 868 | 106 | 13 | int:GSK3B |
| Interaction | YWHAH interactions | KIF13B DLG5 SERBP1 DOCK11 PPFIBP1 KIAA0753 CEP350 DST SYNE2 FLCN NCOA7 PLEC AMOTL2 UTRN PCNT | 6.42e-04 | 1102 | 106 | 15 | int:YWHAH |
| Interaction | HDAC1 interactions | CENPF RPAP3 ARFGEF1 SMC2 DST USP38 TAX1BP1 SYNE2 SMARCC1 PLEC UTRN TOP2A CDC23 PPP6R3 PCNT | 6.78e-04 | 1108 | 106 | 15 | int:HDAC1 |
| Interaction | UBA5 interactions | 6.90e-04 | 133 | 106 | 5 | int:UBA5 | |
| Interaction | ATG4B interactions | 7.14e-04 | 134 | 106 | 5 | int:ATG4B | |
| Interaction | KRT19 interactions | 7.30e-04 | 282 | 106 | 7 | int:KRT19 | |
| Interaction | STEAP1 interactions | 7.52e-04 | 8 | 106 | 2 | int:STEAP1 | |
| Interaction | GBP7 interactions | 7.52e-04 | 8 | 106 | 2 | int:GBP7 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 6.26e-05 | 115 | 66 | 5 | 769 | |
| GeneFamily | Spectrin repeat containing nuclear envelope family | 7.84e-05 | 4 | 66 | 2 | 1252 | |
| GeneFamily | Proteases, serine|STEAP family | 1.30e-04 | 5 | 66 | 2 | 1324 | |
| GeneFamily | Topoisomerases | 1.95e-04 | 6 | 66 | 2 | 1050 | |
| GeneFamily | EF-hand domain containing|Spectrins | 2.72e-04 | 7 | 66 | 2 | 1113 | |
| GeneFamily | EF-hand domain containing|Plakins | 3.62e-04 | 8 | 66 | 2 | 939 | |
| GeneFamily | Dyneins, axonemal | 1.72e-03 | 17 | 66 | 2 | 536 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 1.93e-03 | 18 | 66 | 2 | 91 | |
| GeneFamily | FKBP prolyl isomerases | 1.93e-03 | 18 | 66 | 2 | 910 | |
| GeneFamily | Guanylate cyclase receptors|DENN/MADD domain containing | 3.73e-03 | 25 | 66 | 2 | 504 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 7.63e-03 | 36 | 66 | 2 | 823 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | CENPF ARFGEF1 E2F5 BTAF1 CEP350 DST FAM193A SYNE2 ITSN2 VPS13A AKAP10 ADAM17 DMD TOP1 TOP2A PCNT | 5.79e-07 | 856 | 110 | 16 | M4500 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN | 1.48e-06 | 84 | 110 | 6 | M13008 | |
| Coexpression | MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN | 2.28e-06 | 272 | 110 | 9 | M15123 | |
| Coexpression | GABRIELY_MIR21_TARGETS | 3.73e-06 | 289 | 110 | 9 | M2196 | |
| Coexpression | CHICAS_RB1_TARGETS_GROWING | 8.57e-06 | 242 | 110 | 8 | M2128 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP | GTPBP4 WDR36 WARS1 CENPF RPAP3 CTDSPL2 DYNC2H1 BTAF1 SMC2 ASPM PLEC TOP1 TOP2A | 1.06e-05 | 721 | 110 | 13 | M10237 |
| Coexpression | BUSSLINGER_ESOPHAGEAL_PROLIFERATING_BASAL_CELLS | 1.16e-05 | 70 | 110 | 5 | M40002 | |
| Coexpression | CADWELL_ATG16L1_TARGETS_DN | 1.24e-05 | 71 | 110 | 5 | M12482 | |
| Coexpression | CADWELL_ATG16L1_TARGETS_DN | 1.52e-05 | 74 | 110 | 5 | MM768 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | CWF19L2 RPAP3 VPS13C ARFGEF1 SMC2 CEP350 RBM27 CENPH TAX1BP1 SYNE2 ITSN2 ASPM | 2.06e-05 | 656 | 110 | 12 | M18979 |
| Coexpression | GSE36476_CTRL_VS_TSST_ACT_72H_MEMORY_CD4_TCELL_OLD_DN | 2.22e-05 | 200 | 110 | 7 | M5303 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN | 2.98e-05 | 85 | 110 | 5 | M10575 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C5_PRO_B_CELL | 3.41e-05 | 478 | 110 | 10 | M45785 | |
| Coexpression | CAIRO_HEPATOBLASTOMA_CLASSES_UP | GTPBP4 SERBP1 NOP16 CENPF ARFGEF1 E2F5 SMC2 HS2ST1 ASPM SMARCC1 TOP2A | 5.43e-05 | 612 | 110 | 11 | M4772 |
| Coexpression | FAN_EMBRYONIC_CTX_EX_4_EXCITATORY_NEURON | 7.33e-05 | 166 | 110 | 6 | M39026 | |
| Coexpression | JI_RESPONSE_TO_FSH_DN | 7.34e-05 | 53 | 110 | 4 | M17537 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP | DENND5B GTPBP4 NOP16 CENPF RPAP3 CTDSPL2 DYNC2H1 E2F5 SMC2 IKBIP P4HA1 | 8.54e-05 | 644 | 110 | 11 | M10501 |
| Coexpression | NUYTTEN_NIPP1_TARGETS_UP | KIAA0408 PPFIBP1 ARFGEF1 GBP2 RNF213 SEC31B SEMA3D P4HA1 HS2ST1 NCOA7 STEAP1 CDC23 | 9.37e-05 | 768 | 110 | 12 | M6444 |
| Coexpression | KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP | KIF13B CWF19L2 SERBP1 CENPF CTDSPL2 E2F5 TUBGCP4 SMC2 GTF2A1 RBM27 CENPH HS2ST1 ASPM SMARCC1 TOP2A STEAP1 | 9.57e-05 | 1290 | 110 | 16 | M80 |
| Coexpression | SAGIV_CD24_TARGETS_UP | 1.04e-04 | 22 | 110 | 3 | M4144 | |
| Coexpression | GSE14415_NATURAL_TREG_VS_TCONV_DN | 1.14e-04 | 180 | 110 | 6 | M2961 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C5_CD5_POS_CCL22_POS_MATURE_B_CELL | DENND5B WARS1 NOP16 OTUD5 CCDC141 RRP1 TXLNA CENPH SYNE2 NCOA7 FKBP5 | 1.15e-04 | 666 | 110 | 11 | M45778 |
| Coexpression | LAKE_ADULT_KIDNEY_C6_PROXIMAL_TUBULE_EPITHELIAL_CELLS_FIBRINOGEN_POS_S3 | 1.18e-04 | 181 | 110 | 6 | M39225 | |
| Coexpression | GSE14415_INDUCED_VS_NATURAL_TREG_DN | 1.18e-04 | 181 | 110 | 6 | M2969 | |
| Coexpression | GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_2H_UP | 1.25e-04 | 183 | 110 | 6 | M2993 | |
| Coexpression | BUSSLINGER_GASTRIC_ISTHMUS_CELLS | 1.37e-04 | 458 | 110 | 9 | M40010 | |
| Coexpression | GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_12H_UP | 1.41e-04 | 187 | 110 | 6 | M2984 | |
| Coexpression | FAN_OVARY_CL9_PUTATIVE_APOPTOTIC_ENDOTHELIAL_CELL | 1.56e-04 | 365 | 110 | 8 | M41711 | |
| Coexpression | GSE45365_WT_VS_IFNAR_KO_BCELL_DN | 1.63e-04 | 192 | 110 | 6 | M9987 | |
| Coexpression | GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_8H_DN | 1.82e-04 | 196 | 110 | 6 | M4267 | |
| Coexpression | GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_12H_DN | 1.92e-04 | 198 | 110 | 6 | M4272 | |
| Coexpression | GSE2770_TGFB_AND_IL4_VS_IL4_TREATED_ACT_CD4_TCELL_6H_DN | 1.92e-04 | 198 | 110 | 6 | M6104 | |
| Coexpression | REICHERT_MITOSIS_LIN9_TARGETS | 1.95e-04 | 27 | 110 | 3 | M2483 | |
| Coexpression | AFFAR_YY1_TARGETS_DN | 1.96e-04 | 283 | 110 | 7 | MM1157 | |
| Coexpression | GSE23502_BM_VS_COLON_TUMOR_HDC_KO_MYELOID_DERIVED_SUPPRESSOR_CELL_UP | 1.98e-04 | 199 | 110 | 6 | M8082 | |
| Coexpression | GSE42021_CD24HI_VS_CD24LOW_TCONV_THYMUS_DN | 1.98e-04 | 199 | 110 | 6 | M9595 | |
| Coexpression | CAMP_UP.V1_DN | 1.98e-04 | 199 | 110 | 6 | M2719 | |
| Coexpression | GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_8H_UP | 1.98e-04 | 199 | 110 | 6 | M4266 | |
| Coexpression | GSE10239_KLRG1INT_VS_KLRG1HIGH_EFF_CD8_TCELL_DN | 1.98e-04 | 199 | 110 | 6 | M3070 | |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_NONRESPONDER_7DY_UP | 2.01e-04 | 127 | 110 | 5 | M40905 | |
| Coexpression | GSE17721_POLYIC_VS_GARDIQUIMOD_16H_BMDC_DN | 2.03e-04 | 200 | 110 | 6 | M4032 | |
| Coexpression | GSE15750_DAY6_VS_DAY10_TRAF6KO_EFF_CD8_TCELL_UP | 2.03e-04 | 200 | 110 | 6 | M3580 | |
| Coexpression | HALLMARK_G2M_CHECKPOINT | 2.03e-04 | 200 | 110 | 6 | M5901 | |
| Coexpression | GSE12392_CD8A_POS_VS_NEG_SPLEEN_DC_DN | 2.03e-04 | 200 | 110 | 6 | M7143 | |
| Coexpression | GSE16450_CTRL_VS_IFNA_6H_STIM_IMMATURE_NEURON_CELL_LINE_UP | 2.03e-04 | 200 | 110 | 6 | M7417 | |
| Coexpression | GSE20366_EX_VIVO_VS_HOMEOSTATIC_CONVERSION_TREG_UP | 2.03e-04 | 200 | 110 | 6 | M4313 | |
| Coexpression | TRAVAGLINI_LUNG_PROLIFERATING_NK_T_CELL | 2.16e-04 | 129 | 110 | 5 | M41687 | |
| Coexpression | REICHERT_MITOSIS_LIN9_TARGETS | 2.18e-04 | 28 | 110 | 3 | MM1323 | |
| Coexpression | DIAZ_CHRONIC_MYELOGENOUS_LEUKEMIA_UP | GTPBP4 SPTA1 SPTBN2 TUBGCP4 SMC2 RNF14 ALKBH1 P4HA1 HS2ST1 TAX1BP1 SMARCC1 TOP1 FKBP4 FKBP5 SNX1 CDC23 | 2.42e-04 | 1399 | 110 | 16 | M535 |
| Coexpression | OUILLETTE_CLL_13Q14_DELETION_UP | 2.84e-04 | 75 | 110 | 4 | M9025 | |
| Coexpression | LAKE_ADULT_KIDNEY_C22_ENDOTHELIAL_CELLS_GLOMERULAR_CAPILLARIES | 2.86e-04 | 137 | 110 | 5 | M39241 | |
| Coexpression | MURARO_PANCREAS_DUCTAL_CELL | KIF13B MAOB PPFIBP1 GBP2 RNF213 NCF2 LURAP1L DST SYNE2 SMARCC1 NCOA7 LMAN2 AMOTL2 UTRN TOP1 | 2.87e-04 | 1276 | 110 | 15 | M39173 |
| Coexpression | JOHNSTONE_PARVB_TARGETS_3_DN | GTPBP4 CENPF CTDSPL2 SMC2 CEP350 USP38 TAX1BP1 ASPM FLCN UBXN2A FKBP5 TOP2A | 3.18e-04 | 877 | 110 | 12 | M2241 |
| Coexpression | MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP | 3.31e-04 | 408 | 110 | 8 | M11891 | |
| Coexpression | BUSSLINGER_ESOPHAGEAL_EARLY_SUPRABASAL_CELLS | 3.46e-04 | 79 | 110 | 4 | M40003 | |
| Coexpression | BROWNE_HCMV_INFECTION_16HR_UP | 3.64e-04 | 223 | 110 | 6 | M11383 | |
| Coexpression | MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP | 3.71e-04 | 415 | 110 | 8 | MM1028 | |
| Coexpression | NUYTTEN_EZH2_TARGETS_UP | WDR36 WARS1 SYNE1 ARFGEF1 GBP2 NCF2 SEMA3D P4HA1 FLCN NCOA7 UBXN2A ADAM17 STEAP1 | 3.96e-04 | 1033 | 110 | 13 | M4196 |
| Coexpression | PUJANA_BRCA2_PCC_NETWORK | 4.41e-04 | 426 | 110 | 8 | M9516 | |
| Coexpression | GSE14415_NATURAL_TREG_VS_FOXP3_KO_NATURAL_TREG_UP | 4.61e-04 | 152 | 110 | 5 | M2964 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | GTPBP4 CWF19L2 SERBP1 CENPF RPAP3 DOCK11 VPS13C BTAF1 SMC2 GTF2A1 RBM27 CENPH ASPM SMARCC1 TOP1 PCNT | 1.02e-08 | 532 | 107 | 16 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | CWF19L2 SERBP1 CENPF VPS13C BTAF1 CEP350 RBM27 SYNE2 VPS13A ASPM DMD | 8.37e-07 | 328 | 107 | 11 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | CACNA2D1 CWF19L2 GRIPAP1 SERBP1 CENPF VPS13C BTAF1 CEP350 DST RBM27 SYNE2 VPS13A ASPM DMD PCNT | 9.94e-07 | 654 | 107 | 15 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K5 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | CWF19L2 FAM184A SERBP1 CENPF CTDSPL2 E2F5 BTAF1 SMC2 CEP350 GTF2A1 FAM193A RBM27 CENPH TAX1BP1 SYNE2 VPS13A ASPM SMARCC1 DMD TOP1 TOP2A | 1.04e-06 | 1257 | 107 | 21 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | DENND5B GTPBP4 CACNA2D1 CWF19L2 FAM184A SERBP1 CENPF RPAP3 DYNC2H1 E2F5 TTBK2 FAM193A SYNE2 VPS13A ASPM DMD TOP1 PCNT | 2.10e-06 | 989 | 107 | 18 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.51e-06 | 230 | 107 | 9 | gudmap_developingGonad_e16.5_ovary_1000_k2 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#4_top-relative-expression-ranked_1000 | CACNA2D1 SERBP1 CTDSPL2 TUBGCP4 SMC2 CEP350 SEMA3D VPS13A TOP1 GOLGA1 CDC23 | 3.07e-06 | 375 | 107 | 11 | gudmap_developingKidney_e15.5_cortic collect duct_1000_k4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | GTPBP4 CACNA2D1 CWF19L2 FAM184A CENPF RPAP3 FAM193A SYNE2 ASPM TOP1 | 3.94e-06 | 311 | 107 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | GTPBP4 CACNA2D1 CWF19L2 FAM184A SERBP1 CENPF RPAP3 DYNC2H1 RNF14 FAM193A SYNE2 VPS13A ASPM DMD TOP1 GOLGA1 | 4.07e-06 | 831 | 107 | 16 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_k-means-cluster#3_top-relative-expression-ranked_500 | 5.02e-06 | 188 | 107 | 8 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_500_k3 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_1000 | CENPF CTDSPL2 PPFIBP1 SMC2 CEP350 SEMA3D ASPM SMARCC1 UBXN2A CDC23 | 8.41e-06 | 339 | 107 | 10 | gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_1000_k5 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | CWF19L2 FAM184A SERBP1 CENPF CTDSPL2 E2F5 BTAF1 SMC2 CEP350 GTF2A1 FAM193A RBM27 CENPH TAX1BP1 SYNE2 VPS13A ASPM SMARCC1 DMD TOP1 TOP2A | 1.07e-05 | 1459 | 107 | 21 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.27e-05 | 281 | 107 | 9 | gudmap_developingGonad_e18.5_epididymis_1000_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500_k-means-cluster#5 | 2.32e-05 | 232 | 107 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000 | CACNA2D1 CWF19L2 SERBP1 DNAH10 CENPF VPS13C BTAF1 CEP350 SEMA3D RBM27 SYNE2 VPS13A ASPM DMD TOP1 PCNT | 3.26e-05 | 983 | 107 | 16 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_top-relative-expression-ranked_1000 | CACNA2D1 FAM184A SERBP1 CTDSPL2 TUBGCP4 SMC2 CCDC141 CEP350 SEMA3D VPS13A NCOA7 TOP1 GOLGA1 CDC23 | 3.43e-05 | 774 | 107 | 14 | gudmap_developingKidney_e15.5_cortic collect duct_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_k-means-cluster#1_top-relative-expression-ranked_1000 | 3.75e-05 | 123 | 107 | 6 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_1000_k1 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_500 | DOCK11 GBP2 RNF213 TUBGCP4 SMC2 SYNE2 ASPM SMARCC1 UTRN TOP1 | 4.20e-05 | 409 | 107 | 10 | gudmap_developingGonad_e12.5_ovary_500 |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_top-relative-expression-ranked_1000 | CACNA2D1 CTDSPL2 SMC2 CCDC141 CEP350 SEMA3D DST FAM193A VPS13A NCOA7 CNTN3 AKAP10 UTRN CDC23 | 4.58e-05 | 795 | 107 | 14 | gudmap_developingKidney_e15.5_anlage of loop of Henle_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000 | DENND5B CWF19L2 DOCK11 GBP2 RNF213 SYCP3 TUBGCP4 SMC2 GTF2A1 SYNE2 ASPM SMARCC1 UTRN TOP1 | 5.17e-05 | 804 | 107 | 14 | gudmap_developingGonad_e12.5_ovary_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 5.39e-05 | 192 | 107 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_1000 | KIAA0408 DENND5B DOCK11 SPTA1 GBP2 TUBGCP4 SMC2 GTF2A1 SYNE2 ASPM SMARCC1 UTRN TOP1 TOP2A | 5.98e-05 | 815 | 107 | 14 | gudmap_developingGonad_e11.5_ovary + mesonephros_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#4 | 7.65e-05 | 203 | 107 | 7 | Facebase_RNAseq_e9.5_Mandibular Arch_1000_K4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#1_top-relative-expression-ranked_1000 | 9.18e-05 | 209 | 107 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000_k1 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#2_top-relative-expression-ranked_1000 | 9.46e-05 | 210 | 107 | 7 | gudmap_developingGonad_e18.5_ovary_1000_k2 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_k-means-cluster#5_top-relative-expression-ranked_1000 | 9.74e-05 | 146 | 107 | 6 | gudmap_developingKidney_e15.5_Cap mesenchyme_1000_k5 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.06e-04 | 288 | 107 | 8 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_1000_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000 | DENND5B DNAH10 CENPF DOCK11 CTDSPL2 SYNE1 ARFGEF1 RNF213 SMC2 USP38 ACOT11 TAX1BP1 SYNE2 TOP1 PPP6R3 | 1.29e-04 | 989 | 107 | 15 | Facebase_RNAseq_e10.5_Maxillary Arch_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | CWF19L2 SERBP1 CENPF SMC2 GTF2A1 DST CENPH ASPM SMARCC1 TOP1 | 1.30e-04 | 469 | 107 | 10 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | 1.34e-04 | 298 | 107 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K4 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_top-relative-expression-ranked_500 | CACNA2D1 MAOB DOCK11 CCDC141 RNF14 SEMA3D ACOT11 UBE2QL1 PDZRN3 | 1.53e-04 | 388 | 107 | 9 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_500 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#3_top-relative-expression-ranked_500 | 1.66e-04 | 161 | 107 | 6 | gudmap_developingGonad_e12.5_ovary_k3_500 | |
| CoexpressionAtlas | B cells, B.Pl.AA4-.BM, CD138+ AA4.1- CD43+, Bone marrow, avg-2 | 1.72e-04 | 394 | 107 | 9 | GSM777030_500 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_top-relative-expression-ranked_1000 | CACNA2D1 CWF19L2 DLG5 MAOB DOCK11 CCDC141 IKBIP RNF14 SEMA3D NEO1 ACOT11 UBE2QL1 PDZRN3 | 1.73e-04 | 791 | 107 | 13 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000 | DOCK11 SPTA1 RNF213 SYCP3 SYCE3 SMC2 SYTL4 SYNE2 ASPM SMARCC1 PLEC UTRN TOP1 | 1.82e-04 | 795 | 107 | 13 | gudmap_developingGonad_e16.5_ovary_1000 |
| CoexpressionAtlas | kidney_P0_CapMes_Crym_k-means-cluster#4_top-relative-expression-ranked_1000 | 2.10e-04 | 58 | 107 | 4 | gudmap_kidney_P0_CapMes_Crym_k4_1000 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.32e-04 | 323 | 107 | 8 | gudmap_developingGonad_e11.5_ovary + mesonephros_k2_1000 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.42e-04 | 259 | 107 | 7 | gudmap_developingGonad_e12.5_epididymis_k3_1000 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Medullary collecting duct_emap-28063_k-means-cluster#4_top-relative-expression-ranked_1000 | 3.59e-04 | 261 | 107 | 7 | gudmap_developingKidney_e15.5_Medullary collecting duct_1000_k4 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.99e-04 | 123 | 107 | 5 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k3_1000 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#3_top-relative-expression-ranked_1000 | 4.90e-04 | 275 | 107 | 7 | gudmap_developingGonad_e14.5_ epididymis_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#3_top-relative-expression-ranked_1000 | 5.12e-04 | 277 | 107 | 7 | gudmap_developingGonad_e12.5_ovary_k3_1000 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_top-relative-expression-ranked_1000 | CACNA2D1 SERBP1 SYNE1 SMC2 IKBIP NEO1 DST VPS13A ASPM NCOA7 CNTN3 CDC23 | 5.14e-04 | 772 | 107 | 12 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000 | RNF213 SYCP3 SYCE3 TUBGCP4 SMC2 CCDC141 SYTL4 SYNE2 SMARCC1 PLEC UTRN TOP1 | 5.51e-04 | 778 | 107 | 12 | gudmap_developingGonad_e18.5_ovary_1000 |
| CoexpressionAtlas | dev gonad_e11.5_F_PrimGermCell_Oct_k-means-cluster#3_top-relative-expression-ranked_1000 | 5.60e-04 | 463 | 107 | 9 | gudmap_dev gonad_e11.5_F_PrimGermCell_Oct_k3_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#3_top-relative-expression-ranked_1000 | 5.64e-04 | 369 | 107 | 8 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k3_1000 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_1000 | DENND5B CACNA2D1 FAM184A CENPF DYNC2H1 CCDC141 SEMA3D CENPH ASPM CNTN3 FKBP4 TOP2A | 5.83e-04 | 783 | 107 | 12 | gudmap_kidney_P4_CapMesRenVes_Crym_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#2_top-relative-expression-ranked_1000 | 5.94e-04 | 284 | 107 | 7 | gudmap_developingGonad_e16.5_epididymis_1000_k2 | |
| CoexpressionAtlas | B cells, proB.FrBC.BM, CD19+ IgM- CD45R+ CD43+ HSA+, Bone marrow, avg-1 | 6.37e-04 | 376 | 107 | 8 | GSM538418_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_k-means-cluster#5_top-relative-expression-ranked_500 | 6.53e-04 | 78 | 107 | 4 | gudmap_developingKidney_e15.5_Cap mesenchyme_500_k5 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_k-means-cluster#5_top-relative-expression-ranked_1000 | 6.85e-04 | 79 | 107 | 4 | gudmap_developingKidney_e15.5_Peripheral blastema_1000_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | 6.96e-04 | 139 | 107 | 5 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_500_K4 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_top-relative-expression-ranked_1000 | CENPF CTDSPL2 PPFIBP1 SMC2 CEP350 SEMA3D ALKBH1 ASPM SMARCC1 UBXN2A STEAP1 CDC23 | 7.11e-04 | 801 | 107 | 12 | gudmap_developingKidney_e15.5_ureter tip_1000_flank cortic collct |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#1_top-relative-expression-ranked_1000 | 7.67e-04 | 142 | 107 | 5 | gudmap_developingKidney_e15.5_1000_k1 | |
| CoexpressionAtlas | kidney_e13.5_Podocyte_MafB_k-means-cluster#4_top-relative-expression-ranked_1000 | 7.88e-04 | 82 | 107 | 4 | gudmap_kidney_e13.5_Podocyte_MafB_k4_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500 | 8.74e-04 | 493 | 107 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_k-means-cluster#5_top-relative-expression-ranked_100 | 8.85e-04 | 9 | 107 | 2 | gudmap_developingKidney_e15.5_Cap mesenchyme_100_k5 | |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_top-relative-expression-ranked_1000 | GTPBP4 THNSL1 WDR36 CENPF RPAP3 SPTBN2 RNF213 SYCP3 USP26 RBM27 CENPH VPS13A | 8.91e-04 | 822 | 107 | 12 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_1000 |
| CoexpressionAtlas | alpha beta T cells, preT.DN3-4.Th, Lin-/lo CD25int CD44- CD28+, Thymus, avg-3 | 9.06e-04 | 397 | 107 | 8 | GSM791143_500 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_1000 | CACNA2D1 DLG5 CENPF RNF213 E2F5 CEP350 SEMA3D NEO1 CENPH SYNE2 FKBP5 TOP2A | 9.38e-04 | 827 | 107 | 12 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_1000 |
| CoexpressionAtlas | B cells, proB.FrBC.BM, CD19+ IgM- CD43+ AA4.1+ CD45R+, Bone marrow, avg-2 | 9.67e-04 | 401 | 107 | 8 | GSM399450_500 | |
| CoexpressionAtlas | Stem Cells, SC.MPP34F.BM, Lineage- cKit+ Sca-1+ flk2+ CD34+, Bone marrow, avg-2 | 9.67e-04 | 401 | 107 | 8 | GSM791110_500 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_1000 | CACNA2D1 CENPF GBP2 RNF213 E2F5 CEP350 GTF2A1 NEO1 CENPH ASPM PDZRN3 TOP2A | 9.78e-04 | 831 | 107 | 12 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#5_top-relative-expression-ranked_500 | 9.81e-04 | 150 | 107 | 5 | gudmap_developingGonad_e12.5_epididymis_k5_500 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#3_top-relative-expression-ranked_1000 | 9.83e-04 | 225 | 107 | 6 | gudmap_developingGonad_e14.5_ ovary_1000_k3 | |
| CoexpressionAtlas | B cells, preB.FrC.BM, CD19+ IgM- CD45R+ CD43+ HSA+, Bone marrow, avg-3 | 1.03e-03 | 88 | 107 | 4 | GSM399452_100 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#4_top-relative-expression-ranked_500 | 1.04e-03 | 152 | 107 | 5 | gudmap_developingGonad_e18.5_epididymis_500_k4 | |
| CoexpressionAtlas | B cells, proB.FrA.FL, CD19- IgM- CD43+ CD24intermediate AA4.1+ CD45R+ CD, Fetal Liver, avg-2 | 1.07e-03 | 89 | 107 | 4 | GSM538355_100 | |
| CoexpressionAtlas | alpha beta T cells, T.DPbl.Th, 4+ 8+ TCR-/lo FSChi, Thymus, avg-3 | 1.12e-03 | 90 | 107 | 4 | GSM399397_100 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.18e-03 | 233 | 107 | 6 | gudmap_developingGonad_e12.5_ovary_k5_1000 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_500 | 1.24e-03 | 417 | 107 | 8 | gudmap_developingGonad_e11.5_ovary + mesonephros_500 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.27e-03 | 159 | 107 | 5 | gudmap_developingGonad_e11.5_ovary + mesonephros_k1_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | CACNA2D1 CENPF DYNC2H1 SMC2 USP38 TAX1BP1 SYNE2 CNTN3 DMD TOP1 | 1.29e-03 | 629 | 107 | 10 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2-24ahi.Th, TCRd+ Vg2- CD24+, Thymus, avg-2 | 1.34e-03 | 422 | 107 | 8 | GSM476658_500 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2+24ahi.Th, TCRd+ Vg2+ CD24+, Thymus, avg-3 | 1.36e-03 | 423 | 107 | 8 | GSM476655_500 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#2_top-relative-expression-ranked_500 | 1.38e-03 | 162 | 107 | 5 | gudmap_developingGonad_e16.5_epididymis_500_k2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | 1.55e-03 | 432 | 107 | 8 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.65e-03 | 249 | 107 | 6 | gudmap_developingGonad_P2_epididymis_1000_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_1000 | SERBP1 CTDSPL2 SPTA1 CEP350 SEMA3D DST FAM193A VPS13A CNTN3 UTRN CDC23 | 1.72e-03 | 769 | 107 | 11 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000 |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#4_top-relative-expression-ranked_500 | 1.80e-03 | 172 | 107 | 5 | gudmap_developingGonad_e11.5_ovary + mesonephros_k4_500 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | KIF13B CTDSPL2 VPS13C SYNE1 GBP2 TAX1BP1 SYNE2 ITSN2 UBXN2A UTRN | 2.43e-11 | 178 | 110 | 10 | 01dafd19de04eff459253eaa9a35debf8f3deedf |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.54e-08 | 199 | 110 | 8 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 3.54e-08 | 199 | 110 | 8 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.68e-08 | 200 | 110 | 8 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 3.67e-07 | 183 | 110 | 7 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.81e-07 | 184 | 110 | 7 | a8c6028d745aaa6ee7842259238694cb50ce0526 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.81e-07 | 184 | 110 | 7 | 081d045f3bc98a36f342de7d50f39c9a888dd7eb | |
| ToppCell | Control-Myeloid_G-immature_Neutrophil|Control / Disease group, lineage and cell class | 3.81e-07 | 184 | 110 | 7 | 45f873236f7e90fb78c8e291d3b5b92d121acec9 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.81e-07 | 184 | 110 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.81e-07 | 184 | 110 | 7 | 84c20730cd92b9aaa50077d7b625e37e7f9e91d2 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.81e-07 | 184 | 110 | 7 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.81e-07 | 184 | 110 | 7 | d31d4116d1d196633784863781fa45673607a421 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.81e-07 | 184 | 110 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.81e-07 | 184 | 110 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Control-immature_Neutrophil-|Control / Disease condition and Cell class | 3.81e-07 | 184 | 110 | 7 | c4e8ba82a6aa76c46f05a71d5f1c7926555318cf | |
| ToppCell | Control-immature_Neutrophil|Control / Disease condition and Cell class | 3.81e-07 | 184 | 110 | 7 | 2fdae5c6b3eb2232881d933a8c1061fda3623016 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 4.40e-07 | 188 | 110 | 7 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.25e-07 | 193 | 110 | 7 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-NPC-like-NPC-like_Prolif-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.44e-07 | 194 | 110 | 7 | 7a66bd7d4fc9c6db861cedd2487f241e406869d1 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-NPC-like-NPC-like_OPC-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.44e-07 | 194 | 110 | 7 | 40c6e17e9e48d4fa6da3a0a1066c4c6565a1e096 | |
| ToppCell | moderate-Epithelial-FOXN4+|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.44e-07 | 194 | 110 | 7 | dff3fb10372053951d41e0ccd41aac3ece6009bd | |
| ToppCell | droplet-Thymus-nan-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.63e-07 | 195 | 110 | 7 | 043e2f19d95e94cd5219e2c415f322ed340aa80f | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.03e-07 | 197 | 110 | 7 | 41bdea47b9b1f6415a866a515d1535ea942fdede | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.03e-07 | 197 | 110 | 7 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | mild-low-quality_cells|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.03e-07 | 197 | 110 | 7 | e4331969bd911d1ebb5453f40a7057297b5389b4 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.45e-07 | 199 | 110 | 7 | 101f78fe6dd1bf9e2e4dd5ad8a970312b3540927 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.45e-07 | 199 | 110 | 7 | e0fcec796afe75e42467ca86355b9fc5aa9ae0a1 | |
| ToppCell | Severe|World / Disease group and Cell class | 6.45e-07 | 199 | 110 | 7 | b73ae402b258fcc17e6cd6d6045244eccfe38ef8 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 6.45e-07 | 199 | 110 | 7 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | Control-Control-Myeloid-immature_Neutrophil|Control / Disease, condition lineage and cell class | 6.67e-07 | 200 | 110 | 7 | 118321ac443feb42aee171baccfc4610f00a8822 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.67e-07 | 200 | 110 | 7 | c596a53c0b63c9deaac7d99fcbdd94ecfa96b86c | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 6.67e-07 | 200 | 110 | 7 | 44a68bacdb3d5bf563bd35952176995850933a81 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 6.67e-07 | 200 | 110 | 7 | dc61016c61729f69649cfb21f6264e685ce83dea | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 1.08e-06 | 135 | 110 | 6 | ae2d3a42e567b5bade304c0caa497eb725be3565 | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-Treg_cell_4|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.16e-06 | 152 | 110 | 6 | 6d02b50e9e9ecf820f84a79e46d153a4840a1cfe | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-Treg_cell_4|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 2.16e-06 | 152 | 110 | 6 | eb7ff36792c3c54ac88cfe976f84016b70b1a1d7 | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.72e-06 | 167 | 110 | 6 | 1bd27ffe381d26731b6d4cc5f29b27f1bac4473b | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.85e-06 | 168 | 110 | 6 | a7eb28e15b591997f1aee09501cb20ae18beca08 | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.85e-06 | 168 | 110 | 6 | faaba5ac01c2ebe380f56559374a121979a85a13 | |
| ToppCell | PND28-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-Treg-Treg_G2M|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.41e-06 | 172 | 110 | 6 | 1171e754fd503a0c1152162fcc12a115088a08c7 | |
| ToppCell | droplet-Marrow-BM_(NON-STC)|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.41e-06 | 172 | 110 | 6 | 6004327045f03d832fdabe6cb2f8b1b1db57789a | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.41e-06 | 172 | 110 | 6 | 31c5710fd7ebb221e703545595f5ec0ee3a32bcf | |
| ToppCell | droplet-Lung-nan-18m-Lymphocytic-Proliferating_NK|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.41e-06 | 172 | 110 | 6 | e495efd25aec60b97ac2b5aa861651bd73174a17 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.71e-06 | 174 | 110 | 6 | f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d | |
| ToppCell | droplet-Lung-18m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell-proliferating_NK|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.03e-06 | 176 | 110 | 6 | b17317ac41d3215db55a38cbd3366c0947f7a2a3 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.03e-06 | 176 | 110 | 6 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | facs-Marrow-Granulocytes-18m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.37e-06 | 178 | 110 | 6 | 15a99080e9f669572ab6d82934f324e6714846c1 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.37e-06 | 178 | 110 | 6 | 200308e109abb7e6f8816a6f8cce6d56862d4098 | |
| ToppCell | PND01-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_G2M|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.54e-06 | 179 | 110 | 6 | df4d0b2fe47d2c7def729b3217cb01ced01495ff | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c03-MKI67|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.72e-06 | 180 | 110 | 6 | 1c1b25f1d22518db5469707131510daae84716a3 | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.10e-06 | 182 | 110 | 6 | 9025178ede571e3808d4657ad4892152f336c9b4 | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.10e-06 | 182 | 110 | 6 | c075756cd4bb484ede1be2bcdb9eac60eab0573a | |
| ToppCell | IIF-Lymphocyte-T_NK-T_NK_proliferative|IIF / Disease, Lineage and Cell Type | 6.49e-06 | 184 | 110 | 6 | ab8b45ce40e8c5f66e5c23332a591b4f9cba4ce1 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.49e-06 | 184 | 110 | 6 | d1e0e3b0eed2db8a5b7e3d6f81294667e4ba64e5 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.70e-06 | 185 | 110 | 6 | e64e8c98dd88d91f6501d3fb10b60fd2f3c90af3 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like_Prolif-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.90e-06 | 186 | 110 | 6 | 86d145f965c311189e7996390eef491642417c5c | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.34e-06 | 188 | 110 | 6 | 3177b2c1723268d330d3e9f24f9e24492ace6286 | |
| ToppCell | T_cells-ISG-high_CD4+_T_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 7.34e-06 | 188 | 110 | 6 | 6f8946d4710f6e32c937213f99b790b098b8819c | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like_Prolif-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.34e-06 | 188 | 110 | 6 | 0476d7ee3e0ce78c3c5b111e9ade01098f9ea7ec | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.57e-06 | 189 | 110 | 6 | 203c80030df08ae112f9ae4043709f455d87ce89 | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.80e-06 | 190 | 110 | 6 | 4288189e3a499c395896c950598810b02f401685 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 7.80e-06 | 190 | 110 | 6 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | Calu_3-infected-SARSCoV2|infected / Cell line, Condition and Strain | 8.03e-06 | 191 | 110 | 6 | 2da876d26f37a00dbdf1ee79d724306e8b20f304 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.03e-06 | 191 | 110 | 6 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.28e-06 | 192 | 110 | 6 | 5b7093d5af5ae7b0e6d3a464cc56272440ecedad | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 8.53e-06 | 193 | 110 | 6 | dbf0fe496254320c894568c31e5f9ce63707d1b5 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.78e-06 | 194 | 110 | 6 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c06-MKI67|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.04e-06 | 195 | 110 | 6 | 533818e89d809f01fbb5c4b57932b76aa5c8f30e | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.04e-06 | 195 | 110 | 6 | 93c345e70d6c8ff5d12fd63d73228c1700b804a0 | |
| ToppCell | COVID-19-T_cells-Cycling_NK/T_cells|COVID-19 / group, cell type (main and fine annotations) | 9.04e-06 | 195 | 110 | 6 | 764ed100c28d9bc93ee5ecabc5291c8f184d78da | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.04e-06 | 195 | 110 | 6 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.04e-06 | 195 | 110 | 6 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig-F_2|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.31e-06 | 196 | 110 | 6 | ea8eceacc5d5e1a22b77c31e7c45985dc7bb15de | |
| ToppCell | droplet-Thymus-nan-18m-Lymphocytic-DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.31e-06 | 196 | 110 | 6 | 5ddd314d3def3776dc7da83778d41c6436ca51ac | |
| ToppCell | myeloid-pro-pDC|myeloid / Lineage and Cell class | 9.31e-06 | 196 | 110 | 6 | 70daf4fabb68aecc5cc9f03d6f6495dd29b74a16 | |
| ToppCell | erythropoietic|World / Lineage and Cell class | 9.58e-06 | 197 | 110 | 6 | a52546cebc222050c970e04cec97e4f48ab8fe10 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.58e-06 | 197 | 110 | 6 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | mild-dn_T|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.58e-06 | 197 | 110 | 6 | 07a1f59c83b748825e0708cd1cc7b63a2cb856cc | |
| ToppCell | droplet-Thymus-nan-21m-Lymphocytic-DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.58e-06 | 197 | 110 | 6 | f84f0ddf51208764ab56408d97035bbff562e59d | |
| ToppCell | systemic_lupus_erythematosus-flare|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 9.86e-06 | 198 | 110 | 6 | 4c93ee921d56132d80832d8e94563f32ccf13bbc | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_B-B_lineage-pre_pro_B_progenitor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 9.86e-06 | 198 | 110 | 6 | 8aa4149d2c1cec73cfd654db093252ec8ec5ef68 | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 9.86e-06 | 198 | 110 | 6 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | BAL-Severe|BAL / Compartment, Disease Groups and Clusters | 9.86e-06 | 198 | 110 | 6 | f63cfcc57f46094ea0673bbc70ea443ebaca6176 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.01e-05 | 199 | 110 | 6 | 305a9ade5bbe8e981e7c641c9a5e0c9f8ef60470 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.01e-05 | 199 | 110 | 6 | e9820d5fb4e8b46973c4c50ac5db8fb4a1bf603b | |
| ToppCell | Megakaryocytic-erythropoietic-Erythro-cells-Polychromatic_Erythroblast|Erythro-cells / Lineage, cell class and subclass | 1.01e-05 | 199 | 110 | 6 | 304681a6510c05203aab360ed72bfe929d8e4ac3 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Proliferating-cycling_dorsal_progenitors|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 1.01e-05 | 199 | 110 | 6 | ca17e8c0f5bc2c41ce28351a7418d934404e563b | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_B-B_lineage-pre_pro_B_progenitor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.01e-05 | 199 | 110 | 6 | 8e7f9312dec1e3a92b6a0ccc7baa2d46e89c11f3 | |
| ToppCell | Megakaryocytic-erythropoietic-Erythro-cells-Polychromatic_Erythroblast|Megakaryocytic-erythropoietic / Lineage, cell class and subclass | 1.01e-05 | 199 | 110 | 6 | fa698f00d2dad74d28b4696c8c23dce70f123e52 | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_B-B_lineage-pre_pro_B_progenitor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.01e-05 | 199 | 110 | 6 | 99778178e3ec121802db938db8c5475d19b43fec | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.01e-05 | 199 | 110 | 6 | fba48342066aab41a8bcb20db40a6df0158e1cbe | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.01e-05 | 199 | 110 | 6 | 6b3a0e5d52a30d0eed30e6a670f5b53bc233f70c | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Proliferating|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 1.01e-05 | 199 | 110 | 6 | d8f904f531bfe091b7d8caaa147ea4a03d627995 | |
| ToppCell | Severe-Lymphoid|Severe / Condition, Lineage, Cell class and cell subclass | 1.01e-05 | 199 | 110 | 6 | 928e346b0f31d991ebab12fefb4eb9f4249e601d | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Stem_cells-Neuroepithelial_cell|10w / Sample Type, Dataset, Time_group, and Cell type. | 1.04e-05 | 200 | 110 | 6 | 8f8b8c225cdc79baf16fe04be89bdb65e404a055 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW13-Stem_cells|GW13 / Sample Type, Dataset, Time_group, and Cell type. | 1.04e-05 | 200 | 110 | 6 | d933978b55fefe52cad599b36f6b47a0c7f71f96 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.04e-05 | 200 | 110 | 6 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | Parenchymal-10x5prime-Immune_Myeloid-Macrophage_alveolar-Macro_alv_dividing|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.04e-05 | 200 | 110 | 6 | 0cf7208eab0dc58fbea35e256c5cb55cdd4a4928 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Stem_cells|10w / Sample Type, Dataset, Time_group, and Cell type. | 1.04e-05 | 200 | 110 | 6 | a1f48eca9efb4f3ec3c9ace20f8c9257dd72c4ed | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 1.04e-05 | 200 | 110 | 6 | c5e051f1aac8dda376c342a9932785a23450e073 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.66e-05 | 49 | 71 | 5 | GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN | |
| Computational | Neighborhood of SMC2L1 | 6.19e-05 | 33 | 71 | 4 | GNF2_SMC2L1 | |
| Computational | Neighborhood of TTK | 1.21e-04 | 39 | 71 | 4 | GNF2_TTK | |
| Computational | Neighborhood of SMC4L1 | 2.25e-04 | 84 | 71 | 5 | GNF2_SMC4L1 | |
| Computational | Neighborhood of HMMR | 2.52e-04 | 47 | 71 | 4 | GNF2_HMMR | |
| Computational | Neighborhood of RRM1 | 2.79e-04 | 88 | 71 | 5 | GNF2_RRM1 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.96e-04 | 49 | 71 | 4 | GAVISH_3CA_METAPROGRAM_CD4_T_CELLS_CELL_CYCLE | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.96e-04 | 49 | 71 | 4 | GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CELL_CYCLE | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.96e-04 | 49 | 71 | 4 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CELL_CYCLE | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 3.20e-04 | 50 | 71 | 4 | GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_CELL_CYCLE | |
| Computational | Neighborhood of CKS2 | 3.20e-04 | 50 | 71 | 4 | GNF2_CKS2 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 3.20e-04 | 50 | 71 | 4 | GAVISH_3CA_METAPROGRAM_EPITHELIAL_CELL_CYCLE | |
| Computational | Neighborhood of CDC20 | 4.95e-04 | 56 | 71 | 4 | GNF2_CDC20 | |
| Computational | Neighborhood of CCNB2 | 5.30e-04 | 57 | 71 | 4 | GNF2_CCNB2 | |
| Computational | Neighborhood of RFC4 | 6.45e-04 | 60 | 71 | 4 | GNF2_RFC4 | |
| Computational | Neighborhood of CDC2 | 7.30e-04 | 62 | 71 | 4 | GNF2_CDC2 | |
| Computational | Neighborhood of CENPF | 7.30e-04 | 62 | 71 | 4 | GNF2_CENPF | |
| Computational | Neighborhood of MKI67 | 8.04e-04 | 28 | 71 | 3 | GNF2_MKI67 | |
| Computational | Neighborhood of CCNA2 | 1.03e-03 | 68 | 71 | 4 | GNF2_CCNA2 | |
| Computational | Neighborhood of PCNA | 1.03e-03 | 68 | 71 | 4 | GNF2_PCNA | |
| Computational | Neighborhood of ESPL1 | 1.55e-03 | 35 | 71 | 3 | GNF2_ESPL1 | |
| Computational | Neighborhood of RRM2 | 2.29e-03 | 40 | 71 | 3 | GNF2_RRM2 | |
| Computational | Neighborhood of RFC3 | 2.46e-03 | 41 | 71 | 3 | GNF2_RFC3 | |
| Computational | Neighborhood of CENPE | 2.46e-03 | 41 | 71 | 3 | GNF2_CENPE | |
| Computational | Genes in the cancer module 453. | 3.01e-03 | 44 | 71 | 3 | MODULE_453 | |
| Drug | plakin | 5.65e-09 | 82 | 109 | 8 | CID000018752 | |
| Drug | Clorgyline | 1.50e-06 | 168 | 109 | 8 | ctd:D003010 | |
| Drug | tiapamil | 2.11e-06 | 6 | 109 | 3 | CID000042106 | |
| Drug | Methamphetamine | CACNA2D1 GRIPAP1 MAOB SYNE1 BTAF1 DNAH1 THPO DST FAM193A P4HA1 CENPH ASPM PLEC DMD USH2A UTRN FKBP4 TOP2A STEAP1 PCNT | 9.85e-06 | 1401 | 109 | 20 | ctd:D008694 |
| Drug | 2,3-bis(3'-hydroxybenzyl)butyrolactone | CENPF CTDSPL2 GBP2 E2F5 TUBGCP4 SMC2 SYTL4 CENPH ASPM FLCN NCOA7 AMOTL2 UBE2QL1 FKBP4 TOP2A PCNT | 1.34e-05 | 961 | 109 | 16 | ctd:C029497 |
| Drug | batracylin | 2.27e-05 | 2 | 109 | 2 | ctd:C057924 | |
| Drug | boswellic acid | 2.27e-05 | 2 | 109 | 2 | ctd:C054625 | |
| Disease | Parkinson's disease 23 (implicated_via_orthology) | 1.30e-05 | 2 | 107 | 2 | DOID:0060896 (implicated_via_orthology) | |
| Disease | choreaacanthocytosis (implicated_via_orthology) | 1.30e-05 | 2 | 107 | 2 | DOID:0050766 (implicated_via_orthology) | |
| Disease | autosomal recessive spinocerebellar ataxia 4 (implicated_via_orthology) | 3.90e-05 | 3 | 107 | 2 | DOID:0111611 (implicated_via_orthology) | |
| Disease | Cohen syndrome (implicated_via_orthology) | 3.90e-05 | 3 | 107 | 2 | DOID:0111590 (implicated_via_orthology) | |
| Disease | Autosomal dominant Emery-Dreifuss muscular dystrophy | 7.78e-05 | 4 | 107 | 2 | cv:CN293514 | |
| Disease | Alzheimer's disease (is_implicated_in) | 1.22e-04 | 132 | 107 | 5 | DOID:10652 (is_implicated_in) | |
| Disease | Autosomal Recessive Emery-Dreifuss Muscular Dystrophy | 1.29e-04 | 5 | 107 | 2 | C1450051 | |
| Disease | Autosomal Dominant Emery-Dreifuss Muscular Dystrophy (disorder) | 1.29e-04 | 5 | 107 | 2 | C0410190 | |
| Disease | Emery-Dreifuss muscular dystrophy | 1.94e-04 | 6 | 107 | 2 | cv:C0410189 | |
| Disease | Muscular Dystrophy, Emery-Dreifuss | 1.94e-04 | 6 | 107 | 2 | C0410189 | |
| Disease | testosterone measurement | GTPBP4 CACNA2D1 FAM184A SPEM3 WARS1 KIAA0753 SEMA3D SYTL4 SYNE2 NUFIP2 LMAN2 USH2A UTRN FKBP4 | 2.10e-04 | 1275 | 107 | 14 | EFO_0004908 |
| Disease | asphyxiating thoracic dystrophy (is_implicated_in) | 2.70e-04 | 7 | 107 | 2 | DOID:0050592 (is_implicated_in) | |
| Disease | epidermolysis bullosa simplex (is_implicated_in) | 2.70e-04 | 7 | 107 | 2 | DOID:4644 (is_implicated_in) | |
| Disease | X-Linked Emery-Dreifuss Muscular Dystrophy | 2.70e-04 | 7 | 107 | 2 | C0751337 | |
| Disease | Duchenne muscular dystrophy (implicated_via_orthology) | 3.03e-04 | 36 | 107 | 3 | DOID:11723 (implicated_via_orthology) | |
| Disease | cerebellar ataxia (implicated_via_orthology) | 3.60e-04 | 8 | 107 | 2 | DOID:0050753 (implicated_via_orthology) | |
| Disease | serum IgG glycosylation measurement | 6.49e-04 | 523 | 107 | 8 | EFO_0005193 | |
| Disease | Emery-Dreifuss muscular dystrophy (implicated_via_orthology) | 8.40e-04 | 12 | 107 | 2 | DOID:11726 (implicated_via_orthology) | |
| Disease | lifestyle measurement, maximum cigarettes per day measurement | 1.03e-03 | 122 | 107 | 4 | EFO_0009264, EFO_0010724 | |
| Disease | Headache | 1.64e-03 | 64 | 107 | 3 | HP_0002315 | |
| Disease | Moyamoya Disease | 1.71e-03 | 17 | 107 | 2 | C0026654 | |
| Disease | Malignant neoplasm of liver | 1.81e-03 | 142 | 107 | 4 | C0345904 | |
| Disease | Liver neoplasms | 1.81e-03 | 142 | 107 | 4 | C0023903 | |
| Disease | Malignant neoplasm of breast | WARS1 CENPF DYNC2H1 SYNE1 GTF2A1 TAX1BP1 SYNE2 ITSN2 DMD TOP1 TOP2A | 1.81e-03 | 1074 | 107 | 11 | C0006142 |
| Disease | IGF-1 measurement | 2.04e-03 | 488 | 107 | 7 | EFO_0004627 | |
| Disease | Chronic myeloproliferative disorder | 2.14e-03 | 19 | 107 | 2 | C1292778 | |
| Disease | alpha-tocopherol measurement | 2.37e-03 | 20 | 107 | 2 | EFO_0007898 | |
| Disease | wellbeing measurement, alcohol consumption measurement | 2.49e-03 | 74 | 107 | 3 | EFO_0007869, EFO_0007878 | |
| Disease | triglyceride measurement, body fat percentage | 2.62e-03 | 21 | 107 | 2 | EFO_0004530, EFO_0007800 | |
| Disease | muscular dystrophy (implicated_via_orthology) | 2.62e-03 | 21 | 107 | 2 | DOID:9884 (implicated_via_orthology) | |
| Disease | Seckel syndrome | 2.87e-03 | 22 | 107 | 2 | C0265202 | |
| Disease | Disease Exacerbation | 3.11e-03 | 165 | 107 | 4 | C0235874 | |
| Disease | spermatogenic failure (is_implicated_in) | 3.14e-03 | 23 | 107 | 2 | DOID:0111910 (is_implicated_in) | |
| Disease | electrocardiography | 3.23e-03 | 530 | 107 | 7 | EFO_0004327 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| WAKKLEQLNAMRDQD | 141 | Q9UPW8 | |
| LDQLKDNMEKLNTIW | 391 | Q9BXU7 | |
| DNMEKLNTIWKPKSE | 396 | Q9BXU7 | |
| ALEADMTKWEQKYLE | 561 | Q9Y2J4 | |
| WLELCNLITDKEMLK | 206 | Q9UJX2 | |
| ESWFMDKNDNELLKL | 421 | Q05D32 | |
| LDKHMSKEETQDLWE | 131 | Q13686 | |
| QEELAWKIAKMIVSD | 631 | O43572 | |
| QLAELREKSQEWMDK | 831 | Q86UK0 | |
| DNMKLPEQQTEKAEW | 1436 | Q9Y6D6 | |
| LDLQKYWDLMNLSEK | 411 | Q9BZE4 | |
| KMLVAKDNWVLSSEI | 396 | Q8WXI4 | |
| NEMLKDSTQWLEAKE | 2576 | P11532 | |
| EDSKGVKELMKQWQD | 2726 | P11532 | |
| TKQRMLTEDWELFKQ | 151 | P78312 | |
| DKMAHDLEIKWTENL | 631 | Q8NB25 | |
| TMELLTQNWDLSKKL | 981 | Q8IZT6 | |
| KSWKECLQMLISLQD | 81 | A0A3B3IT52 | |
| MLIEDVDALKSWLAK | 1 | Q9P2N5 | |
| KKIFDNWMTIQELLT | 1031 | Q9UPQ7 | |
| EIWALSDLNKDGKMD | 61 | Q9NZM3 | |
| EDVMNILDWKTKQSN | 61 | P48200 | |
| WVEMKSKALLNEETV | 106 | Q5VTT2 | |
| EEWDNMTMKELLDKL | 141 | P27338 | |
| KEMTLDEWKAIQNKD | 286 | Q8NC51 | |
| SWEMDTKEKLEQAAI | 256 | Q13451 | |
| WNRLMVVSDEKENIK | 301 | Q8NGM1 | |
| LWKVDLKVEDMNLFT | 571 | Q14667 | |
| KDQEWSEKMDQLEKE | 131 | Q92805 | |
| VMTDLEDKNEWKNCI | 226 | Q12907 | |
| EWKKAEEQLALATSM | 136 | P19878 | |
| ASEEDNVKLLKFWMT | 541 | Q8NFG4 | |
| EKQRMEQKWESLKDE | 251 | Q86W92 | |
| EEKLEMLQWKLSAAG | 146 | Q96S65 | |
| KQMLTEIDSKWQELN | 4596 | Q03001 | |
| ELMNWLNEVHDKLSK | 5621 | Q03001 | |
| NLKLDDMLSELRDKW | 6781 | Q03001 | |
| ESDEEWSMNKKLIDL | 791 | Q2TBE0 | |
| KDLQWEMELLQSELT | 391 | Q8TDM6 | |
| ETNWHKEKMELLDQF | 11 | Q6ZU52 | |
| QKDIWDIQMRSKSLE | 571 | P32456 | |
| WKLMVEESDLLGQLK | 341 | Q9UGJ1 | |
| DDKIKFWLEMNSIVD | 161 | A8MYU2 | |
| QRKETDWKVMKEELQ | 746 | O95613 | |
| ISEKWQKSEAIMEQL | 96 | Q70UQ0 | |
| KLMKRLNTEWSELEN | 86 | P13674 | |
| ALDKMEKEWSTILFN | 1161 | Q9P2D7 | |
| VETWLNDLALEMKKT | 1496 | Q8NCM8 | |
| QLELLEEDSMKWRAK | 871 | Q6ZP82 | |
| KLWLQQSIKNVMDDS | 151 | Q15329 | |
| TEQEMEEWLITLKKI | 256 | Q5JSL3 | |
| KASMKSILENLSDLW | 1816 | O14981 | |
| CWKSENEKLLTQMES | 621 | P49454 | |
| LNKLIMKSQQESWDL | 136 | Q9H3R5 | |
| MKSQQESWDLEEKLL | 141 | Q9H3R5 | |
| EQLGSKRMDSLKWDQ | 81 | O95873 | |
| WVDKMQEDLVTLAKT | 36 | P54289 | |
| EKDTEAIKSLQVEMW | 331 | P23610 | |
| QMEKQALAAWDKELI | 1891 | Q5VT06 | |
| IDNKIMSQWEEKDPL | 571 | Q6ZUT9 | |
| INESIESIKWMIEEK | 121 | Q8IV03 | |
| KESWEMNSEEKLEQS | 256 | Q02790 | |
| AETQQEKWMLEEKVK | 716 | Q4V328 | |
| EKAVKEILDTWENMK | 1396 | Q8IVF4 | |
| DTKVLLNWEQVKAME | 916 | Q9P232 | |
| WIEQQMLEDKKRATD | 376 | Q96G74 | |
| EKLIQEMTVTWEEKL | 401 | Q9NQT8 | |
| AEIQMDSWKLDKKLD | 461 | Q96C24 | |
| LVIQMTDDEKYLWKD | 191 | P23381 | |
| IQDKKVLMDNSLWEA | 5151 | O75445 | |
| MSLEELIKWLNMKDE | 2566 | P46939 | |
| ADELAKMELKWKEQV | 556 | Q86VP1 | |
| DHMLVKELSWKQQDE | 56 | Q96KN7 | |
| KDLANADWNMIEKAI | 461 | Q4G0N8 | |
| WDLDMQKAEEQEEKI | 136 | Q8IZU3 | |
| SEKNKELCEWLTQME | 7786 | Q8NF91 | |
| NVIDEWTEKALQKME | 1656 | Q8WXH0 | |
| WENLSNHVTDMDKKL | 2581 | Q8WXH0 | |
| MKLQSLLQKWEEFDE | 4831 | Q8WXH0 | |
| WTQNLKELQTMKADL | 5861 | Q8WXH0 | |
| DEEQLLQKVMNLWEK | 356 | P04053 | |
| AQMDNKSEVQLWLLK | 621 | Q8NI08 | |
| IAKLQQSDIWKMENE | 301 | Q7LGA3 | |
| KWMKNEEALDTESSE | 281 | Q92859 | |
| LNESLKVLKMQGWEE | 126 | P56182 | |
| SEKMLWQFLKVTLEQ | 461 | Q9NQW1 | |
| KEIDSMQKQRLDWLD | 631 | Q2KHM9 | |
| AEWQDFLDSLQKRKM | 161 | Q9Y3C1 | |
| LLEALEMYKDDWNKV | 631 | Q92922 | |
| SISKEKWNMEEVVLE | 481 | O95025 | |
| MESRKDITNQEELWK | 1 | Q9UHE8 | |
| MESRKDITNQEEIWK | 1 | Q6NZ63 | |
| NEEKDAWDVKMLLEQ | 306 | P78536 | |
| EQVLMELKTLWENKL | 36 | P52655 | |
| TELSTKEMRNNWEKE | 4666 | Q63HN8 | |
| KALEEMESKEWLEKN | 386 | Q9UBS8 | |
| KDSVLWQDMKETNTE | 36 | A1L167 | |
| DTKTLKMWFLEESNE | 1691 | Q96RL7 | |
| KMWFLEESNETEKIA | 1696 | Q96RL7 | |
| TKEMESIWNLQKQDP | 666 | Q7Z417 | |
| KMNESDIWFEEKLQE | 301 | Q13596 | |
| KLWIDEKMLTAQDVS | 1291 | O15020 | |
| LQNALDKMIDWATQK | 51 | Q0P670 | |
| LELRNMEWKNSDDAK | 516 | A0A1B0GUW6 | |
| RDLENWEKDIKQKDM | 26 | Q9H6T3 | |
| EEMEKNWQELLHETK | 71 | A1L190 | |
| DVWEEMDANKNKIKL | 381 | Q6IQ55 | |
| MKDVDNLKSIKEEWV | 1 | P68543 | |
| LEKTWNMSVSEKLQD | 91 | Q8IYQ7 | |
| HLKEQEDWTDSKLSM | 1916 | Q709C8 | |
| IMEKHDNWDLTQLKV | 246 | Q15166 | |
| EAMKEQLEQLKEHWD | 1576 | P02549 | |
| QSEDMTAKEKLLLWS | 291 | Q15149 | |
| EQDLENKEMSKEWFL | 901 | Q8NB14 | |
| KQQWEMKTEEADLLQ | 716 | O95347 | |
| KQIDDRKEWLTNFME | 656 | P11388 | |
| RILEAWEMNEKKQAE | 436 | Q5H9R7 | |
| DWRKEMTNEEKNIIT | 281 | P11387 | |
| WESSNKALLEMAEEK | 436 | P40222 | |
| LWDLEDKKLINQMRN | 316 | Q8NI36 | |
| EWKTQMEETKAQDIL | 71 | P40225 | |
| DAQTFAEWKVDMLKL | 141 | P17050 |